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ABSTRACT

Thakur, Raviraj Vijay. Ph.D., Purdue University, December 2015. A General Purpose
Programmable Microfluidic Platform for Screening and Optimization of Biological
Assays. Major Professor: Steven Wereley, School of Mechanical Engineering.
Screening is a fundamental process in today’s medicine and clinical diagnostics,
comprising of several processes ranging from finding new target molecules having the
desired therapeutic potential to identifying biomarkers for accurate diagnosis of a spectrum
of diseases. Current high throughput screening (HTS) platforms leverage sophisticated
robotics to perform a large number of experiments very quickly, an otherwise
unmanageable task with manual labor. However, these systems are capital intensive which
limit their use to large pharmaceutical companies or larger research labs. Additionally,
reagent consumption is of the order of 10-100 µL per assay, which leads to substantial
consumables cost. Recently proposed droplet microfluidic technologies have the potential
to substantially reduce assay costs by performing reactions using nanoliter volumes at very
rapid rates. However, their incorporation into screening workflows is limited owing to
various technological challenges such as on-chip droplet storage for long incubation assays,
fluid waste due to large dead volumes, lack of programmable control over individual assay
droplets, etc.
To address aforementioned problems, three novel microfluidic designs are proposed in
this work which not only facilitates assay miniaturization but also enable extraction of high
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information content, compared to the existing methodologies. First, an on-demand droplet
generator is developed which enables complete spatiotemporal control over individual
droplets. It consists of programmable on-chip pumps that convert pipetted samples into
nanoliter sized droplets surrounded by an immiscible oil phase, each of which can be used
as an independent reaction chamber. The design enables variable volume mixing of
multiple droplets and long term droplet storage inside the microfluidic chip, making it an
excellent candidate for pharmaceutical co-crystal screenings. Second, an on-chip droplet
dilution scheme is developed which generates a train of droplets with a tunable
concentration gradient, a feature highly desired for high definition profiling of
pharmaceutical drug molecules. Finally, a microfluidic device is developed for delivering
nanoliter quantities of reagents over paraffin embedded tissue sections mounted on
microscopic slides. This attribute demonstrates the feasibility of programmable
microfluidics for seamless integration within tissue diagnostics workflow for biomarker
discovery.
.
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CHAPTER 1. INTRODUCTION

In this chapter, I introduce basic microfluidic approaches intended primarily to two types
of screening applications, enzyme-inhibitor screening and protein crystallization screening.
Three distinct well-known platforms, i.e. valve-based, droplet based and well-based are
reviewed and along with their drawbacks/limitations. Finally, more specific problem
statements are proposed and milestones are set for developing a high definition screening
approach.

1.1

Microfluidic Approaches to In-Vitro Screening

Screening of multiple compounds at various reaction conditions for a desired
biological/biochemical activity is at the heart of drug discovery and development.
Screening is used in diverse applications, ranging from finding a target molecule for a
particular pharmacological interest (e.g., small molecule library screens) to optimizing
properties of drug compounds (e.g., salt/co-crystal screens). For example, enzymeinhibitor screens are of huge relevance considering the critical regulatory role played by
many enzymes in cellular pathways. Any genetic changes in their structures cause
unexpected cellular functions, potentially leading to several disease mechanisms. Protein
kinases and β-secretase are examples of some enzymes which are key targets in many
cancers and Alzheimer’s disease respectively. Inhibitors are molecules that stop catalytic
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activity of particular enzymes by binding at specific sites. Screening of such inhibitors is a
two-step process, first a library of potential inhibitors is assayed against a particular target
enzyme at single concentrations, called as binary or sparse matrix screens. The successful
candidates or hits of this primary run are further quantified for efficacy/potency and
specificity study. In this second step, inhibitor concentrations are varied across 4-6 orders
of magnitude to evaluate a potency parameter called half-maximum inhibitory
concentration (IC50), which is the drug concentration needed to inhibit a particular enzyme
(refer fig(1)). A lower IC50 value implies high potency. These quantitative assays are thus
important in studying the pharmacodynamics and in order to predict potential toxicity.
Optimization assays such as co-crystal and protein crystallization screening are central
from a manufacturing perspective. Protein crystallization requires sparse screening of
potential precipitants that may cause crystallization. Concentration screens of the hits
identifying the regions of the phase diagrams likely to produce high quality crystals (fig
(2)). Cocrystals are solid materials composed of two or more molecules in the same crystal
lattice, typically composed of an API (active pharmaceutical ingredient) molecule and a
non-API component (often called coformer). Significant interest currently lies in the
preparation of cocrystals as potential solid forms for pharmaceutical drug delivery, due to
their ability to fine-tune physico-chemical properties of drug compounds. With 40% of
NCEs (new chemical entities) currently in development in pharmaceutical companies
exhibiting poor solubility, the resultant poor absorption and insufficient reproducible
bioavailability are often regarded as the major challenge in bringing a molecule to the
market. Formulating NCE as a cocrystal can have a dramatic effect on the bioavailability.
The therapeutic potential of pharmaceutical cocrystals is well known, but the rate limiting
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steps in realizing their full potential lie in the screening methods for possible forms and
developing scalable cocrystallization techniques. Finding optimum conditions for
cocrystallization requires screening large numbers of conditions such as different
concentrations of API and coformer under different solvent compositions.
Performing these reactions manually is an impossible task, hence use of sophisticated
robotics are generally used to automate these processes. These systems/ liquid handling
work stations are often called as high throughput screening (HTS) systems and perform
various fluidic operations such as sample pipetting, mixing with reagents, incubation, and
reaction readouts at sufficiently high speeds. These units use plastic well plates (96 or 384
well formats) for compartmentalizing assay reagents and are capable of performing
reactions in parallel. HTS provides a fast, robust and fully automated approach for
performing laboratory experiments using robotic systems; an otherwise intractable task
with manual labor. However, typical HTS systems are capital intensive (e.g., robotic liquid
handling systems cost hundreds of thousands to millions of dollars), which limit their use
to large pharmaceutical companies or larger research labs. Access to HTS capabilities by
small to midsize labs (e.g., university research and biotech startup companies) demands
machine time and library sharing, reducing overall productivity. Additionally, HTS
systems typically require per-sample volumes of 2-100 µL, which leads to substantial costs
of consumables for screens that require thousands of reactions. Moreover, primary screens
are typically run at single concentrations of samples, which results in poor performance
characteristics and missed variable conditions, with numerous false positives/negatives.
This is caused by the fact that every drug will have a different potency and its response
with respect to its concentration change can be quite complex. One solution to this issue is
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to integrate the serial dilution operations for every compound subjected to a primary screen.
However, this would lead to large number of experiments with huge sample volumes
required per compound. Miniaturization is thus essential for high quality screens that not
only perform binary or single point assays, but rather investigate every compound in great
quantitative detail by performing fine concentration screens.

1.1.1

Droplet Microfluidic Techniques

Droplet microfluidics is a relatively new field that is revolutionizing HTS (Casadevall i
Solvas & deMello 2011). Droplets of aqueous samples or reagents encapsulated in an
immiscible carrier phase inside microfluidic channels offer a new paradigm for
compartmentalization (Christopher et al. 2008). Highly mono-disperse droplets can be
produced by co-flowing the aqueous fluids with an immiscible phase through simple
microfluidic geometries such as T-junctions (Baroud et al. 2010). Droplet volumes can
range from picoliters to nanoliters; thus allowing further miniaturization of assay volumes
by 3-6 orders of magnitude compared to standard HTS systems. Droplets can be easily
mixed, incubated and transported by pressure-driven flow to various sections of
microfluidic chips. Droplet contents can be detected to perform all essential steps of a
biological screen. Minimal cross-talk between droplets and high rates of generation are
some of the intrinsic characteristics of droplet microfluidics making it superior to existing
robotic liquid handlers (Niu et al. 2011).
There are mainly two ways by which screening is performed using droplets, cartridge
technique and droplet library (Song et al. 2006,Guo et al. 2012). Both techniques can
perform screening of reagents against a specific target as well as concentration screens to
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further quantify their performance. In cartridge techniques, potential reagents are first
loaded as long plugs in a glass capillary. The plugs are separated by an air gap to avoid
cross talk. The plugs and air spacers are surrounded by an immiscible phase (usually
fluorinated oils) to avoid evaporation. These plugs are introduced into a T junction where
they are merged with the target sample. Fig 3 shows an example of this cartridge technique
where 140nL plugs of 40 different reagents were stored in a glass capillary. The plugs
merged with a buffer and a substrate as shown in Fig 3. The flow rates of reagents were
changed with respect to buffer to achieve the different compositions required for the
gradient screen. This approach, however has many disadvantages. First, loading reagent
plugs into cartridges is a time-consuming process and becomes impractical with an
increasing number of reagents. Second, since the same glass tip is used while loading
different reagents, a great possibility of cross-contamination exists. Third, concentration of
reagents can be varied only over one order of magnitude by varying the flow rates of
individual streams.
The Droplet library is now most popular process for high throughput screening (FallahAraghi et al. 2012, El Debs et al. 2012, and Brouzes et al. 2009). In this ensemble approach,
generated droplets are collected off chip for storage and are re-injected them again in
another microfluidic device for detection. This results in ultra-fast screening and the
technology has been commercialized by RainDance technologies (USA). For instance, to
screen a chemical library for a biological activity against a target enzyme, library elements
are first converted into droplets and are then collected together to generate a droplet library.
The library is re-injected in another microfluidic chip where each library droplet is mixed
with sample enzyme droplet and subsequently detected for biological activity. However,
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collected droplets can have different reaction conditions such as varying concentration, and
a bar-coding scheme such as fluorophore or DNA template must be used to label droplet
contents. In the case of fluorophore labeling, the dynamic range of current optical detectors
limits the number of screening elements, while DNA labeling requires extra off-line
processing to read the sequences. Also, avoiding cross-talk and maintaining droplet
stability for an ensemble storage often requires finding the optimum conditions for
surfactant composition and use of suitable oils as carrier phases. Also, making a library is
a labor intensive process and is not practical for smaller libraries. Moreover, changing the
concentration of compounds over larger orders of magnitude is almost an impossible tasks.

1.1.2

Valve-Based Screening Platforms

Microfluidic channel based devices using soft polymer materials are largely popular in
the lab-on-chip community because of their inherent ability for system integration and
automation.(Grover 2003, Unger et al. 2000, Grover et al. 2006) These devices use on-chip
valves and pumps that can be directly integrated in the device to perform complex fluidic
operations. There is a variety of designs for microfluidic vales. They are mainly classified
as active and passive valves. Depending on their physical mechanisms these can be further
classified into magnetic, electrostatic, piezoelectric, electrochemical, pneumatic etc. The
pneumatic valves gained popularity due to their easy fabrication and possible integration
with microfluidic devices. The pneumatic valves consisted of two layers; fluid and
control/gas sandwiched between membranes made up of an elastomeric substance such as
PDMS. Quake’s group demonstrated a series of pneumatic valve design. The valves were
fabricated using a method called multilayer soft lithography (Erickson 2004). The
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schematic of such valves is shown in Figure 6. In the idle state these valves are open and
pneumatic pressure was applied on the PDMS membrane to deflect it in order to close the
fluidic channel. Mathies’ pneumatic valves gained great popularity due to the practical
implementation in a PCR microchip was carried out by many researchers. A schematic of
such a valve is shown in Figure 7. The valve is closed in its normal state. When a vacuum
source is applied in the control layer, PDMS membrane deflects and allows for the passage
of fluid. Peristaltic micropumps made up of three layers of PDMS were suggested by
Quake and comprised of three pneumatically operated microvalves in series. When these
valves are actuated in a predefined sequence, they lead to fluid pumping. The motion is
unsteady peristalsis and following a period which depends on the frequency of actuation.
Such valve-based systems are highly programmable and are capable of parallelization
and/or multiplexing. These systems have been used for various screens such as protein
crystallization and enzyme kinetics.(Dittrich & Manz 2006)

1.1.3

Fixed Well-Based Systems

Well based systems are gaining popularity especially in coarse screening applications
(Schmitz et al. 2009). These are miniaturized versions of standard microwell plates and do
not require any pumping mechanisms. Ismagilov’s etal. first introduced this concept, a
multiplexed reactions systems called SlipChips (Shen et al. 2010). It consists of two plates,
a bottom plate with different reagents that need to be screened and a top plate for the target
sample. The patterns on both the plates are complementary such that after sliding the plates
on top of each other, reagent wells are aligned with sample wells. Diffusion based mixing
occurs and proceeds towards reactions. The bottom reagent plate is generally loaded by
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automated pipetting operations as shown in Figure 3. Reading the reactions results is quite
convenient because of the uniformly spaced well locations. Several screening applications
such as protein crystallization, PCR etc. have been demonstrated using SlipChips. Wellbased system have a particular advantage over rest of the systems that sample evaporation
is greatly minimized without any extra modifications to fabrication process. In case of
valve and droplet based devices, many optimizations or designs modifications are generally
needed for avoiding sample evaporations in prolonged reactions. Also, the technique uses
some standard components from liquid handling stations for preloading the bottom assay
plate with screening reagents.

1.2

Current Issues with Miniaturized Screening Platforms

Screening is quite a complex endeavor and all the three platforms, i.e. droplet based,
valve-based and well based described in section 1.1 fail to provide a perfect solution.
Moreover, they are able to screen only under certain conditions for particular applications.
For example, droplet microfluidics works tremendously well for binary screens, while
SlipChips are ideal for sparse screening in protein crystallization due to the stiff substrate
material. Valve-based chips developed by Kennis group. are (Schudel et al. 2009; Thorson
et al. 2011; Thorson et al. 2012) only prevalent for co-crystal screening where porosity of
PDMS is used as an for controlled evaporation. Quite clearly, there is an unmet need for a
fully automated platform capable of performing high definition screens. Droplets
surrounded by carrier oil is the most desired configuration for performing reactions.
Droplets can be generated serially at very high frequencies (100 Hz-10 kHz) and fluidic
interfaces can be efficiently controlled by proper choice of surfactants. Sample evaporation
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is greatly minimized due the presence of immiscible phase. However, current droplet
microfluidic approaches lack overall programmability and control over individual droplets.
Syringe pumps suffer from large dead volumes in intermediate tubings. Even though assay
requirements can be fulfilled with a few nanoliters of sample/reagent volume, a larger
volume may be trapped in the tubing which connect external pumps to the microfluidic
chips Moreover, generating a concentration gradient in droplets is quite challenging.
Valve-based approaches are exceptional in terms of automation, where pneumatic inputs
to individual valves can be computer controlled. Pipetted samples can be actively
controlled with on-chip membrane pumps. However, samples/reagents are in contact with
microchip substrate and often prone to cross-contamination due to carry-over fractions in
case of successive runs. Also, with increasing numbers of experiments, the chip complexity
increases. Sample dilution of high orders is very difficult to achieve in these systems.
Finally, sample evaporation is a tremendous issue owing to porous nature of chip material
(poly-dimethylsiloxane). Well-based systems are quite attractive only for sparse screening
applications with single concentration assays.

1.3

Problem Statements

With a vision of performing high definition screens and for mitigating issues discussed in
section 1.2, following design criterions should be used:
1) World-to-chip fluidic interfacing: It deals with issues/challenges of bringing
reagents on to microfluidic platform. The method should be capable of working
with large number of samples/reagents without any dead volumes. Only in such
scenarios, microfluidics device can be truly said to be saving sample volumes.
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2) On-chip dilution: Ability to vary concentration of each reagent over 4-6 orders of
magnitude is essential for high definition secondary screen. The dilution scheme
should be robust, reproducible and should work with all the reagents. Moreover,
the number of data points should be sufficiently large to ensure high levels of
statistical confidence.
3) Minimal sample consumption: The platform should be capable of working with
smallest sample volumes possible, approximately in nanoliter range.
4) Automated operations: The fluid operations must be capable of complete
automation requiring least human intervention.
5) Parallelization for increased throughput: Ability to perform large number of
experiments in parallel is essential when dealing with large libraries.

1.4

Solution Approach

In this thesis, I propose a novel combination of droplet microfluidics and valve-based
technology for generating high quality screenings of enzyme inhibitors. This combination
not only eliminates several disadvantages with individual approaches, but also enables
statistically high confidence and large quantity of data per assayed compound. Valve-based
technology is used to generate droplets of controlled composition, i.e. size and
concentration and droplet manipulations across the microfluidic chip are completely
automated using Microfluidic Innovations controller unit (Fig 7). The platform facilitates
following:
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1) Conversion of a directly pipetted sample into a finite number of droplets of
predetermined composition in fluorinated oil. The droplets are controlled with onchip peristaltic pumps and entirely programmable.
2) Concentration gradient in droplets for evaluation of IC50 value for every compound
that is interrogated.
3) Combinatorial mixing of enzyme, fluoregenic substrate and varying concentrations
of inhibitor.
4) On-chip incubation and storage for long durations. No labelling strategies are
required since droplet locations are programmed prior to operations.
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Figure 1. Screening platform using droplet microfluidics (Sjostrom et al. 2014)
Reproduced with permission from Royal Society of Chemistry.

Figure 2. Droplet library creation for binary screening (Guo et al. 2012). Figure
Reproduced with permission from Royal Society of Chemistry.
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Figure 3. SlipChips for sparse screening of compounds (Du et al. 2009). Figure
reproduced with permission from Royal Society of Chemistry.

Figure 4. Screening platform using valve based microfluidics (Goyal et al. 2013).
Reproduced with permission from Royal Society of Chemistry.
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Figure 5. A high level architecture of the proposed programmable droplet microfluidic
device for droplet based biological screening applications.
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CHAPTER 2. FABRICATION, AUTOMATION AND EXPERIMENTAL SETUP

In this chapter, I introduce fundamental concepts of microfluidic on-chip membrane
valves and pumps. A detailed fabrication protocol is described for manufacturing the three
layer microfluidic devices used in the subsequent chapters. Finally, a valve/pump
automation strategy is explained using an open source microcontroller platform,
ARDUINO along with PYTHON based front-end user interface.

2.1

Introduction to Microfluidic Valves and Pump

There exists a variety of designs for microfluidic vales. A detailed summary can be found
in a review paper by Oh and Ahn, 2006. They are mainly classified as active and passive
valves. Depending on their physical mechanisms these can be further classified into
magnetic, electrostatic, piezoelectric, electrochemical, pneumatic etc. The pneumatic
valves gained popularity due to their easy fabrication and possible integration with
microfluidic devices. The pneumatic valves consisted of two layers; fluid and control/gas
sandwiched between membranes made up of an elastomeric substance such as PDMS.
Quake’s group demonstrated a series of pneumatic valve design (Unger et al., 2000). The
valves were fabricated using a method called multilayer soft lithography. The schematic of
such valves is shown in Figure 8. In the idle state these valves are open and pneumatic
pressure was applied on the PDMS membrane to deflect in order to close the fluidic channel.
Mathies’ pneumatic valves gained a great popularity due to its practical implementation in
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a PCR microchip was carried out by many researchers (Lagally et al., 2001). A schematic
of such a valve is shown in Figure 6 . The valve is closed in its normal state. When a
vacuum source is applied in the control layer, PDMS membrane deflects and allows for the
passage of fluid. Due to their increased functionality we have implemented these valves in
our designs. Fluid transport is an important task in all microfluidic devices. Several
micropumps exist differing from each other by their fluid transport mechanisms. The
peristaltic micropumps made up of three layers of PDMS were suggested by Quake and
comprised three pneumatically operated microvalves in series. When these valves are
actuated in a predefined sequence, they lead to fluid pumping. The motion is unsteady
peristaltic and follows a period which depends on the frequency of actuation. Several
actuation sequences exist and one of the popular sequences is shown in Figure 7. A detailed
study of flow rates and physical mechanisms was performed by Chuang etal., 2012 and
Amin et al., 2008.

2.2

Microfluidic Chip Fabrication

The microfluidic devices designed and fabricated in the following chapters were made
by combining on-chip valves and peristaltic pumps with microchannels for automated and
precise manipulation of small fluid volumes. These devices are comprised of three distinct
layers of a flexible polymer called poly-dimethylsiloxane (PDMS), and are fabricated using
a standard protocol known as soft lithography. Soft lithography works on principle of
replica molding, where a master mold is made to imprint channels into the bulk PDMS.
Various methods for creating master molds exists such as hot embossing, injection molding.
However, UV lithography based molds using an epoxy photoresist SU8, serve the purpose
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best in terms of cost-effectiveness and ease of fabrication. The first step in creating these
micromolds consists of creating CAD designs for desired patterns using commercial
software such as AutoCAD. Figure 8 and Figure 9 shows design of a fluidic layer and its
counterpart control layer for a 3 layer microfluidic device with on-chip valves and pumps.
The use of alignment marks on individual layers helps to align the fabricated layers later
during chip assembly process. The CAD designs are converted into high resolution binary
photomasks as shown in Figure 10. The mask when exposed with a UV illumination source
from one side, transfers the same geometric design pattern on a thin, light sensitive layer
SU8 layer. The second step in the chip fabrication process consists of microfabrication of
SU8 molds using photolithography process. A 4” Silicon water (University wafers Inc) or
a glass wafer (75mmX50mm; purchased from Ted Pella Inc.) can be used as a substrate for
SU8 depositions. For enhanced adhesion of the photoresist and long term durability of
molds, it is imperative to follow a stringent cleaning protocol both involving acid and
solvent cleaning. Initially wafers are incubated in an acetone bath for 12 hours to remove
any impurities. To clear any residual organic debris, the wafers are incubated for 30
minutes in a piranha both with 3:1 volume ratio of concentrated sulfuric acid and hydrogen
peroxide. Next, wafers are cleaned with DI water and isopropanol solution and incubated
for 20 minutes at 1500C to remove any leftover water from the surface of the substrate.
Further wafer cleaning can be performed using 60 sec of oxygen plasma exposure at 50
mTorr for enhanced photoresist adhesion. Next, negative SU8 photoresists (Microchem
Inc.) is spin coated on the cleaned wafers to achieve uniform photoresist coating. Different
formulations of SU8 are commercially available optimized for certain film thicknesses. For
the microfluidic devices designed in the following chapters, channel depths varied from 5
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µm to 100µm and details about the SU8 series used, spinning rates are provided in Table
1. For example, SU 3025 is spun at 4000 rpm to achieve fluidic channel depths of 25µm
and at 1250 rpm to achieve control layer depth approximately 40µm. It is made sure that
no air bubble is trapped in SU8 during the spin coating step. Spin coating is followed by a
pre-exposure bake at 650C and followed by 95 0C for variable incubation time depending
on channel thickness (refer Table 2). The wafer is then allowed to cool down to room
temperature. The photoresist is then exposed to a UV light source (10 W/cm2) through a
photomask for certain duration depending on the film thickness of SU8. Optimal exposure
conditions (Table 3) while maintaining hard contact between photomask and recipient
substrate ensures completely vertical sidewalls. Overexposure of UV radiation results in
inclined sidewalls which changes the cross sectional area of the resulting microfluidic
devices. The exposed wafers are then post baked at 650C followed by baking at 95 0C for
certain amount of incubation time as stated in Table 4 the baked wafers are cooled to room
temperature and immersed in a developer solution for 2-5 minutes (refer Table 5). For a
negative photoresists such as SU8, the areas which are exposed to UV light get cross-linked
and remain strongly adhered to the substrate in the presence of developer solution, whereas
the regions that are not exposed to UV light get dissolved and washed away in the developer
solution. The developed substrates are thoroughly rinsed with isopropyl alcohol and airdried with filtered pressurized nitrogen. The molds are baked at 2250C for further rigidity.
The third key step in the fabrication of three layer microfluidic devices is replica molding,
which relates to transferring the patterns of SU8 molds to PDMS. The pre-polymer mix
and curing agent from 184 Silicon kit (Ellsworth Adhesives) is mixed in 10:1 by weight
and is degassed in a vacuum chamber to expel trapped air bubbles. The degassed mixture
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is poured over the SU8 masters and is baked at a temperature of 750C for 3-5 hours. A great
precaution is taken while peeling the thick PDMS layers off the SU8 molds. Few drops of
methanol of a detergent can help to ease the peel off process. A featureless, flexible, thin
membrane was obtained by spin coating the PDMS mixture at 1200 rpm which serves as
an intermediate layer between fluid and control layer.
The final step in the fabrication work flow is microchip assembly. Several holes are
punched in control layer using Harris unicore punches, which serve as access holes for
supplying pressure/vacuum to individual on chip valve. Additionally, many through holes
are punched for inlet/outlet reservoirs for fluids. A corona plasma discharge is used for
irreversible bond the membrane layer to the control layer. Using a microscope with a 4X
objective lens, fluidic layer and control layers are aligned with the help of alignment marks.
Figure 11 and Figure 12 shows the aligned on-chip valves, pumps and photos of fully
aligned 3 layer PDMS microfluidic device.

2.3

Valve Automation

A general purpose chip was built from the pneumatic valves and peristaltic pumps
described above. The overall chip layout is shown in Figure 2.4. The pneumatic lines from
control layer were extended to the edges of the chip. Using hypodermic needle of
appropriate sizes, access holes were drilled into PDMS control layer. A manifold provided
and manufactured by Microfluidic Innovations was used to hold the chip and made external
off chip connections possible. The access holes were connected to 3/2 solenoid valves
(Burkert 6144 Germany) using plastic tubing. The solenoids valves had two inputs for
pressure and vacuum. Approximately 20V (DC) was applied to the solenoids. This
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switched it’s from idle to active and in turn changed from pressure state to vacuum state.
Response of the pneumatic on chip valves to solenoid actuation was very fast due to the
small membrane thicknesses and small dead volumes used throughout the study. To control
individual solenoids addressing different valve locations on chip, they were connected to
an automatic relay board (NI-PCI-6516 National Instruments). There were 32 digital
outputs to which solenoids were connected and they all operated in an independent manner.
There exists a variety of programs that can control relays in an automated fashion. In the
beginning of project, a NI-DAQmx programmed supplied by National Instruments was
used and LABVIEW environment provided a direct control over relay board. Later, a
runtime system using C++ (Microsoft Basic Visual 6.0) was created which allowed easier
control and more flexibility. Briefly the runtime was provided with a text file of commands
which was converted to a high level language and fed into microcontroller for controlling
relay. A portable system was built by Microfluidic Innovations LLC and details of control
infrastructure can be found elsewhere. An overall control platform can be seen in (Fig 17).
A detailed description can be regarding control infrastructure and programming
architecture can be found elsewhere (Amin et al., 2008).
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Figure 6. Schematic for a 3 layer on-chip membrane valve.

Figure 7. A 5-phase actuation sequence for a 3 valve peristaltic pump.
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Figure 8. CAD design for fluidic layer of a three layer microfluidic device.
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Figure 9. CAD design for fluidic layer of a three layer microfluidic device.
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(a)

(b)

Figure 10. (a) fluid layer and (b) control layer photomasks for patterning SU8
films using UV lithography.

Inlet reservoirs
connected via
individual valves

3 valve on-chip
peristaltic pump

Figure 11. CAD drawing showing a design of microfluidic chip after alignment of
fluid and control layer.
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pressure/vacuum entry
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microfluidic chip

Figure 12. Photograph of a 3 layer PDMS microfluidic chip connected to PEEK
tubing via a manifold.

Figure 13. PDMS microfluidic device analyzed under a upright microscope.

Figure 14. Photograph of microfluidic controller from Microfluidic Innovations.
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Table 1. Spin coating parameters for various SU8 film thicknesses.
Channel
depths
(µm)
10
25
35
50
70
100

Spinning step 1
Speed Acceleration Dwell
(rpm)
(rpm/sec)
(sec)
500
100
10
500
100
10
500
100
10
500
100
10
500
100
10
500
100
10

SU8
series
3010
3025
3025
3025
3050
2100

Spinning step 2
Speed Acceleration Dwell
(rpm)
(rpm/sec)
(sec)
3000
300
35
3000
300
35
1900
300
30
1400
300
25
1200
300
25
300
300
35

Table 2. Pre-exposure bake parameters for various SU8 film thicknesses.
SU8
series
3010
3025
3025
3025
3050
2100

depths (µm)
10
25
35
50
70
100

Pre-exposure bake
at 650C
5
10
10
15
20
25

Pre-exposure bake
at 950C
5
10
12
15
25
35

Table 3. UV exposure dose for various SU8 film thicknesses.
depths (µm)
10
25
35
50
70
100

SU8
series
3010
3025
3025
3025
3050
2100

UV exposure dose
mJ/sq.cm
200
180
200
250
270
240
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Table 4. Post-exposure bake parameters for various SU8 film thicknesses.
SU8
series
3010
3025
3025
3025
3050
2100

depths (µm)
10
25
35
50
70
100

Post-exposure
bake at 650C
2
4
5
7
10
15

Post-exposure
bake at 950C
4
8
10
15
20
25

Table 5. Development time for various SU8 film thicknesses.
depths (µm)
10
25
35
50
70
100

SU8
series
3010
3025
3025
3025
3050
2100

Developing time
(minutes)
1
2
3
3.5
5
12
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CHAPTER 3. DROPLETS-ON-DEMAND

Sample discretization is the first step that needs to be performed in all
biological/chemical assays. In this chapter, I propose a novel method for converting
samples and assay reagents into nanoliter droplets using programmable on-chip peristaltic
pumps. Each of these droplets are used as an independent reaction chambers.

3.1

Abstract

Droplet microfluidics offers an effective way for compartmentalizing samples and
reagents for various biological and/or biochemical assays. However, an active control over
size and frequency of individual droplets is quite difficult to achieve with off-chip pumping
mechanisms such as syringe pumps. In this article, we propose the use of programmable
microfluidic architectural components for spatiotemporal droplet control. On-chip threevalve diaphragm pumps were used to drive both dispersed and carrier phases towards a
microfluidic T-junction. Individual droplet sizes and spacing were varied by controlling
the number of pump cycles for injection and break-off. Droplet generation frequency was
modulated by adjusting valve actuation rate. Droplet sizes were quantified for various
pump parameters to identify the parametric space for stable and reliable droplet generation.
Complex droplet trains with variable drop sizes and spacing were created by programming
the desired pump states. On-demand combinatorial merging and mixing of two droplets in
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various volumetric ratios was performed to in a divergent mixing geometry to demonstrate
utility of this technology. All these features are a technological advancements extending
the capabilities of current droplet microfluidics platforms.

3.2

Background

Assay miniaturization and automation is advancing at a thrilling pace, with novel
technologies greatly impacting all phases of drug discovery and development. In recent
years, droplet microfluidics has emerged as a promising tool for performing biological and
biochemical assays (Song et al., 2006, Teh et al., 2008). Droplets of aqueous samples and
reagents surrounded by an immiscible carrier phase inside microfluidic channels offers a
new paradigm for miniaturized assays. Mass transport across interfaces can be modulated
using appropriate surfactants, enabling effective compartmentalization as just as in
standard assay well plates. Highly mono-dispersed droplets can be produced by flowing
the aqueous and oil phases through simple microfluidic geometries such as T or cross
junctions. Material for the chip is chosen such that oil phase preferentially wets the surface,
thus encapsulating aqueous droplets. Droplet volumes can range from picoliters to several
nanoliters; thus allowing further miniaturization of assay volumes by ~3-6 orders of
magnitude compared to standard liquid handling systems. Droplets can be easily mixed,
incubated and transported by pressure driven flow to various sections of microfluidic chips
and droplet contents can be detected to perform all essential steps of a biological screen.
Minimal cross-talk between droplets and rapid rates of generation are some of the intrinsic
characteristics of droplet microfluidics that make it superior to existing robotic liquid
handlers.
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External pumping remains a popular choice for driving fluids in microchannels for
droplet production. Typically, syringes filled with desired fluids are connected using PEEK
tubing to microfluidic chips. Droplet production is achieved via syringe pumps. Fluid
interfacial instabilities arise at the junction (T or cross shaped) where two immiscible
phases meet, leading to a segmented flow patterns. Flow rates, driving pressure and
surfactant concentrations can be varied to change the force dynamics at the junction leading
to different droplet sizes (picoliters to nanoliters) and generation frequency (up to ~10Khz).
While simple in nature and robust, performing assays using external pumping mechanisms
have three inherent disadvantages. First, because droplet formation is a result of a complex
break up process due to interfacial instabilities, external pumps are notoriously difficult to
adjust to obtain desired conditions in droplets. Since droplet size and generation frequency
are coupled parameters and thus it can be difficult to achieve the same desired droplet size
at varied frequencies (Garstecki et al., 2006). It was observed that, at the same flow rate
ratio of aqueous and oil phases, increasing individual flow rate magnitude not only
increases the periodicity of the break up process but also affects the resultant droplet sizes
(Christopher et al., 2008). Even though droplet size can be increased by increasing aqueous
phase flow rate, the outcome is not instantaneous as the flow needs to be stabilized for
several minutes for consistent droplet production. This transition time is attributed to the
channel deformations in response to variations in source pressure as well as for settling
pressure transients in the syringe pumps to generate a steady state flow. Second, detection
and monitoring of reactions in continuously moving droplets leads to substantial
difficulties in data acquisition and analysis (Cristobal et al., 2006; Lim et al., 2013, and
Cecchini et al., 2011). Since, droplet generation rates are generally quite high, droplets are
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transported continuously to outlets in few seconds. For assays with longer time scales, this
continuous motion of droplets complicates the time-dependent study of the droplet contents.
Thus, most studies have relied on equilibrium by later re-injecting the droplets for endpoint measurements. A few devices have demonstrated methodologies for studying
enzyme-inhibition reaction kinetics (Sjostrom et al., 2013,Song and Ismagilov, 2003).
However, such devices were limited to reaction time scales ranging from seconds to up to
few minutes. This disadvantage can be partially mitigated by designing longer fluidic
channels (Frenz et al., 2009) which comes at the expense of larger pressure drops.
Moreover, this approach is not practical for assays requiring several minutes to hours of
storage or incubation periods. To address this issue, use of trapping zones using
geometrical obstacles (Huebner et al.,2009, Schmitz et al., 2009, Shen et al., 2010)and
optical forces (Baroud et al., 2007, Hu and Ohta, 2011, Neuman and Block, 2004) have
been made for holding the droplets stationary in the microfluidic device. However, lack of
control over number of droplets generated compared to active trap sites may lead to many
of them going to waste reservoirs without being analyzed. An orthogonal approach stores
droplets off-chip, then re-injects them upon reaction completion for detection has several
issues. However, because each droplet can represent a different reaction condition such as
varying concentration and/or chemical content, droplets lose their spatial information when
pooled together off-chip, and a bar-coding scheme must be used to label droplet contents
as suggested by Brouzes et al., 2009. For fluorophore labeling, the dynamic range of
current optical detectors limits the number of screening elements, while DNA labeling
requires extra off-line processing to read the sequences. Furthermore, avoiding cross-talk
and maintaining droplet stability for an ensemble storage often requires finding the
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optimum conditions for surfactant composition and use of suitable oils as carrier phases
(Guo et al., 2012). Finally, syringe pumps suffer from large dead volumes, especially from
world-to-chip interface. Even though assay requirements can be fulfilled with a few
nanoliters of sample/reagent volume, a larger volume may be trapped in the tubing which
connect external pumps to the microfluidic chips.
Owing to the above limitations, several efforts have been directed towards the
development of drop-on-demand systems for biological screening; an approach primarily
inspired by inkjet printing technology. For example, optically induced interfacial forces
such as the Marangoni effect have been used for controlled droplet break up and
manipulations (Baroud et al., 2007, Fradet et al., 2011). Such devices utilized standard
external pumps to drive both immiscible phases. A focused laser beam was used to exert
sufficient force to hold the advancement of the interface at T-junction. The droplet was
formed only after withdrawal of the laser beam and its size was controlled by adjusting the
laser pulse duration. Recently, passive systems that combine pressure driven flow and
integrated microfluidic valves have gained considerable attention. Membrane based
microfluidic valves act as binary gates for the passage of fluid and can be easily controlled
to open or close. These valves were integrated with the aqueous inlet channel just before
the T-junction and valve timings were controlled to dispense known quantities of liquid
into the junction, thus controlling their rate of generation and droplet sizes (Zeng et al.,
2009). Use of external electromagnetic valves (Churski et al., 2013) were made to precisely
control droplet volume. Although, these methods are promising, they still require an
external pumping source and/or a pressure controller for reliable droplet production.
Secondly, for many pharmaceutical screening applications here number of reagents is
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typically large (from ~100 to 10K), use of such external valves present system integration
difficulties due to huge number of off-chip valves, corresponding tubings for individual
inputs and possible dead volumes. More recently, a combination of on-chip peristaltic
pumps for driving aqueous samples and a syringe pump for carrier oil phase was used to
perform an off-chip PCR with different droplet volumes (Zeng et al., 2013). However,
because of the complex break-up between the pulsatile flow from peristaltic pumps and
constant flow rate of the syringe pump, the observed droplet sizes and frequency of
generation were found to be consistent only for a certain range of pump parameters.
Clearly, the current state-of-the-art droplet microfluidics can benefit from an active
control of the droplet generation and manipulation process.

An on-chip pumping

mechanism can allow precise control over drop size, generation frequency and number of
droplets produced. It can facilitate long-term on-chip storage. Further, it has potential to
completely nullify dead volume issue and simplify world-to-chip interfacing. To
circumvent the above limitations and to increase flexibility for performing various
biological assays/screens in droplet format, we propose a programmable drop-on-demand
microfluidic platform for spatiotemporal control over individual droplets. The platform
consists of on-chip peristaltic diaphragm pumps for modulating both immiscible phases. A
programmable microvalve controller was used to control the pump states such as number
of pump cycles for injection and break-off, rate of valve actuation etc. leading to a complete
control over individual droplet sizes, spacing and generation frequency.
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3.3
3.3.1

Experimental Section
Microfluidic Chip Layout and Fabrication

The microfluidic chips were designed with normally closed pneumatic diaphragm vales
as previously described by (Grover , 2003). The chip was comprised of three layers; fluid,
flexible membrane and control. Each layer was made up of poly-dimethylsiloxane
elastomer (PDMS, Sylguard 184 kit) using soft lithography protocol. For detailed
discussion about fabrication procedure and chip assembly, please refer the section 2.2. The
following lithography protocol was used to fabricate master molds for casting channels in
PDMS. Negative tone photoresist SU8-3050 (MicroChem Corp.) was used to create a
master mold for generating patterns on PDMS layers. The photoresist was spun at 4000
rpm on piranha-cleaned Si wafers to achieve fluid and control layer depths of ~40 µm. A
pre-exposure bake was carried at 650C for 20 mins followed by 950C for 25 min. Dark field
chrome masks with appropriate features were used to expose the substrate under UV light
of sufficient intensity. The substrates were developed for 2-3 min to obtain well defined
mold patterns followed by a post-bake at 1800C for 30 min for enhanced adhesion to the
substrate. A mixture of PDMS pre-polymer and curing agent (10:1 wt) was poured over
the molds and baked at 700C for 3 hrs. The PDMS layers were carefully peeled off from
the mold to avoid any damage to the molds. Several holes were punched for input/output
reservoirs and for pneumatic access lines. A thin flexible membrane was obtained by
spinning PDMS mixture on a glass wafer at 1200 rpm followed by a bake at 900C for 30
min. The membrane layer was bonded irreversibly to control bulk using oxygen plasma.
As a final step, the fluid layer was aligned with the control layer using an inverted
microscope and bonded reversibly simply by pressing against the control layer. To make
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channel surfaces more hydrophobic, Aquapel (PPG Industries) was flowed in the channels
for 2 min followed by a bake at 600C for 10 min.

3.3.2

Microfluidic Valve Controller Unit

The chip design consisted of a T junction (100 µmX100µm) with three reservoirs, two
serving as inlets for pipetting aqueous and oil phase respectively, and the third as waste
outlet. For generating droplets, both the phases were driven towards the junction by two
separate 3-valve on-chip peristaltic pump (section 2.1). Each valve diameter was 400µm
and consecutive valves were separated by a distance of 75µm. Source pressure/vacuum
was distributed through a set of external DC solenoid valves, each connected independently
to an on-chip valve. These membrane valves of the pneumatic pumps act as binary gates.
Vacuum deflects the membrane upwards into the control chamber, allowing for the passage
of fluid while pressure deflects the membrane downwards where it obstructs the fluid.
Peristaltic fluid flow was generated by actuating these valves in a 4-stage sequence as
shown in Figure 15. Valve state was altered by applying a DC voltage to the solenoids. For
precise control over valve actuation, number of pump strokes, pump operation sequence,
and actuation frequency, we used AssayMark Controller, a technology developed by our
research group, and commercialized by Microfluidic Innovation's (Figure 15). The
software-controlled platform takes a pre-defined set of instructions that contain
information about desired pump states. Fluorinert oil FC3283 (3M Corp.) and DI water
were used as a carrier and aqueous phases, respectively. A food color was injected into DI
water for better visualization and a portable USB microscope with a color camera (ViTiny
UM07) was used to capture image sequences.
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3.4

Results

Droplet generation was performed in two steps. First, the aqueous phase was injected
into the T junction. The number of pump strokes determined the droplet size. Secondly,
droplet break-off was achieved using carrier oil phase pump and the number of pump
strokes determined the spacing between the droplets. A runtime instruction code was
assembled prior to the experiments through which various droplet patterns were obtained.
We define the pump time period as the time required for completion of one pump stroke.
This time period can be reduced or increased by modulating the frequency of valve
actuation.

3.4.1

Programmable Control over Droplet Sizes and Spacing

To demonstrate active control over droplet production, droplets of various sizes were
generated by alternatively pumping both the phases through the microfluidic T-junction.
Active control over droplet size is demonstrated by generating droplets with increasing
volume as shown in Figure 16 and Figure 18. The droplet sizes were changed by changing
the number of pump strokes from 1 to 5. For this experiment, the pump period was kept
constant at 600ms for both the pumps. The droplet sizes were quantified using ImageJ
software by using an intensity threshold method (refer supplementary section). Figure 18
shows variation of droplet size as a function of number of pump strokes. The minimum
droplet size observed was approximately 1.25nL, corresponding to one unit pump stroke
injection. The data was fitted using a linear fit with a very high co-efficient of determination
(R2>99%). The linear behavior with respect to number of pump stroke is of tremendous
importance demonstrating the potential of this technique for reliable metering. The
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experiment was also performed at two different actuation pressures and droplet sizes were
found to increase with increasing system pressure (Figure 18). Similarly, the spacing
between successive droplets was changed by controlling the number of oil pump strokes.
An instruction code with different droplet sizes and spacing was compiled and run to yield
complex droplet train patterns as shown in Figure 25and Figure 26.

3.4.2

Droplet Size vs Pump Actuation Frequency

To determine maximum rate of droplet generation, experiments were performed by
varying the time period of both aqueous and oil pumps independently. For first set of
experiments, the time period of aqueous pump was varied during the injection step, keeping
the time period for the oil pump constant at 600ms. The external solenoid valves in the
controller unit had a minimum response time of 15ms as prescribed by supplier; leading to
a minimum possible time period of 60ms for one pump cycle in a 4-stage pump sequence.
The observed droplet size is plotted against the number of pump strokes at various pump
frequencies in Figure 19. Three distinct regions can be clearly identified based on droplet
generation behavior. In the first region, for pump periods less than 120ms (or pump
frequency>8.33 Hz), no droplets were generated. The interface between the two phases
oscillated rapidly at the junction, but no fluid was injected into the junction to be available
for possible break-off. The minimum pump time period value for which droplet generations
observed (~120ms) was significantly higher than pump actuation limit (60ms) and thus
raised a possibility that the response time of membrane must be higher than the solenoid
valves. We quantified the response time of the elastic membrane valve by indirectly
measuring the deflection at various actuation frequencies (refer 3.4.3). Three valve states
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were identified as fully closed valve for high frequencies, partially open valve at
intermediate frequencies and fully open valve at low frequencies. Thus, for actuation
periods less than 120ms, the membrane did not have sufficient time to respond to the
applied source vacuum and all the three valves of the pump remained completely closed.
For time periods ranging from 120ms to 400ms, the membranes deflected partially into the
control chamber. In this second region, the droplet formation commenced, but droplet sizes
had a higher uncertainty and the droplet volume varied non-linearly with respect to number
of pump strokes before break-off (Fig 12). The size dependence transitioned into linear
behavior and can be clearly seen with coefficient of x 2 decreasing with increasing time
periods. At around 400ms pump period, membranes were fully deflected and consistent
linear behavior was observed. For higher pump periods, the droplet size did not appreciably
change as the pump stroke volume was already near its maximum.
The frequency of the peristaltic pump driving the oil phase was varied to examine the
possible effect on the break-off process. Similar to the results of aqueous pump frequency
study, three distinct regions were observed as shown in Figure 20. At very high pumping
frequencies, the effective flow rate of oil was close to zero and no droplets were generated.
At intermediate values shown by regime 2 in Figure 19, droplets were pinched-off only for
multiple pump strokes. Finally, in the third region, consistent droplets were generated only
with one pump stroke of carrier oil phases. This analysis all together provides pump
operational regimes where droplet generation process is most stable and reliable.
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3.4.3

Oscillatory Response of Membrane Valves

In order to better understand the droplet generation behavior at various pump time
periods (as seen in Figure 20and Figure 19), we quantified the deflection response of the
PDMS membrane at various actuation frequencies. A microchannel filled with a dye color
was used to identify three membrane states; i) fully open, ii) partially open and iii) fully
closed valve; as shown in Figure 21. The mean intensity of the valve area (shown with a
red circle) varied depending on the valve state. The maximum deflection of the membrane
was limited by the control layer depth (~40 µm). In order to calibrate for the deflection,
fully open and fully closed valves filled with dye were used as reference points indicating
a deflection of 40 µm and zero deflection respectively. Next, the valve was triggered at
various frequencies and the valve area mean intensity minus background was plotted as a
function of time. The intensities were normalized using the maximum value corresponding
to a fully open valve. The normalized intensity response is plotted in Figure 22 as a function
of time for various pump periods. For low pump frequencies, membranes had sufficient
time to deflect as the peaks were closed to unity. However, at larger frequencies insufficient
time resulted in partial or no deflection. This can be seen from intensity time curves for
80ms period where peak height is ~1% of the fully deflected valve. We used the normalized
peak heights to calculate the approximate deflection of the membrane with 40 µm depth,
thickness representing the maximum allowed deflection. The deflection behavior can be
seen from Figure 21 and clearly depicts frequency dependent behavior of droplet injection
and break-off process three regions are identified. For time periods less than 100ms, the
membrane did not have sufficient time to deflect and resulted in no net flow. For
intermediate values (100ms – 400ms), the membrane underwent partial deflections. For
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larger pump periods, the pump valves were fully open and resulted in most stable droplet
generation.

3.4.4

Combinatorial Mixing

Mixing of different reagents in variable volume ratios is essential in combinatorial
chemistry applications. Recently, (Korczyk et al. 2013) demonstrated mixing and dilution
of droplets using passive traps. Although they demonstrated various useful capabilities
such as droplet dilutions, the operational parameters such as mixing volumes were dictated
by device geometry which could not be altered on-demand. On the other hand, we
employed above programmable operations to mix droplets of various sizes and
compositions using a diverging section geometry (Baroud et al. 2010). As the first droplet
entered the divergent mixing chamber (refer Figure 23), it decelerated due to increased
hydrodynamic drag from an increased surface area. The second droplet, having a greater
speed, then merged with the first, leading to the desired fusion and subsequent mixing. The
pumping parameters were chosen such that droplet volumes linearly changed. (a) shows
two droplets of same dye but different volumes coalesced inside the mixing chamber in the
ratio 1:4, 1:8 and 1:12. Figure 24 shows two droplets of different dyes (blue and red)
merged and mixed in different volumetric ratio (1:1, 2:1 and 4:1). Finally, Figure 24 shows
the resultant combinatorial mixing leading to various reactions conditions in successive
droplets.
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3.5

Conclusion

In this chapter, we have successfully proposed and demonstrated the use AssayMark
software programmable microvalve controller for controlling the size and motion of
nanoliter droplets inside microfluidic channels. The use of on-chip pumps facilitates active
control over individual droplet size and thus can be used for combinatorial mixing of
reagents in variable volumetric ratios. This provides tremendous ability to change
experimental conditions from droplet to droplet. The droplet generation was thoroughly
characterized as a function of various pump control parameters such as actuation frequency,
number of strokes for injection and break-off and regions for stable droplet generation were
identified. Complex droplet train patterns were generated using simple software scripts
enabled by the platform, which would otherwise be impossible to generate using standard
off-chip syringe pumps. We envisage this technology to be applicable in various
applications ranging from enzyme-inhibitor studies, protein-protein interactions and many
other applications. As a next step, we will try to integrate standard auto-samplers to inject
chemical components from a library well plate directly into the on-chip reservoirs for
complex combinatorial chemistry assays. We will also incorporate additional components
such as heaters and on-chip sensors for more complex droplet based assay automation
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Figure 15. (a)Microfluidic Innovations Controller Unit. (b) Binary pneumatic valve and (c)
3-valve on-chip peristaltic pump.

Figure 16. Droplet generation using on-chip peristaltic pumps.
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(c)

Peristaltic Pumps for oil and
aqueous phase

Figure 17. (a) Generation of monodisperse droplets through a microfluidic T junction.
(b) Multiple droplets stored in a serpentine channel. (c) Micrograph showing zoomed
in view of T junction during droplet break off process. The least droplet size was
observed to be around 1nL.
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Figure 18. Variation of droplet sizes as a function of number of pump strokes during
injection stage. Droplet are generated using (a) single pump stroke, (b) two pump
strokes, (c) three pump strokes and (d) four pump strokes. (e) A linear fit in the droplet
size variation implies reliable metering.
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Figure 19. Droplet size dependence of frequency of on-chip pumps during injection
stage. The linear dependence is achieved at pump time periods of 400ms.
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Figure 21. Micrographs for fully closed, partially open and fully open valves.
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Figure 22. Oscillatory response of membrane valves. At higher frequencies, the
membrane lags the input signal and leads to completely closed valves.

Figure 23. Merging and subsequent mixing of two droplets in a divergent geometry.
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1. Variable volume
droplet generation
2. Merging

3. Product
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Detailed view

Figure 24. (a) Self merging of droplets. (b)Combinatorial mixing of two droplets for
variable volume mixing. (c) Droplet storage channel showing successive droplets with
different mixing ratio.
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(a)

(b)

Figure 25. Complex droplet train patterns with different droplet sizes. (a) Linear change
in droplet size. (b) Three replicates of each droplet size.

(a)

(b)

Figure 26. Complex droplet train patterns with different droplet spacings. (a)
Monodisperse droplets seperated by user defined oil spacings. (b) Variable drop size and
spacing demonstrating software controlled aspect of the device.
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CHAPTER 4. MICROFLUIDIC DROPLET DILUTOR

Varying concentrations of compounds from drop-to-drop basis is quite challenging in
droplet microfluidics, mostly limited by lack of control over individual droplets. In this
chapter, I present an on-chip microfluidic droplet dilution strategy by using three valve
peristaltic pumps, for general purpose screening applications in biology.

4.1

Introduction

Concentration screens are central to most biological/chemical assays in drug discovery
and they reveal key quantitative information about dynamics of the assay components. A
few mainstream examples are evaluation of Michaelis rate constant(Km) for enzymesubstrate kinetics, determining half-maximal inhibitory concentration of a drug (IC50) by
constructing dose-response data and estimating association/dissociation constants (Kd) of
protein complexes from binding affinities measurements, etc. These parametric studies are
also important for optimization assays such as co-crystal and protein crystallization screens
for generating concentration dependent phase diagrams. Consequently, dilution is a
fundamental step in concentration screens. Manual pipetting of samples and mixing with
dilution buffers in various ratios is a time consuming task. Many robotic liquid handlers
are capable of alleviating this issue by performing automated serial dilutions; however,
they are quite expensive and generally consume sample in microliter range. Lab-on-chip
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devices, which utilizes various microfluidic methods for liquid manipulations, are
particularly promising with respect to lower sample consumption and process automation.

4.2

Existing Microfluidic Dilution Techniques

Urbanski et al. 2006 pioneered a cascaded dilution scheme using a ring mixer. In their
device, sample and buffer were mixed in 1:1 ratio to generate 2 fold dilution in one step.
Higher order dilutions were achieved by serially combining the mixed product again with
the buffer. Although the process was completely automated, the dilution ratio per step is
invariant and is imposed by the channel geometry. Moreover, the process is time
consuming for dilutions of higher orders, as it requires several intermediate metering,
mixing and temporary storage steps. Paegel et al., 2006 modified the concept by employing
a single intermediate storage reservoir. However, their approach was susceptible to cross
contamination from intermediate runs. Microfluidic serial dilution networks (Kim et al.,
2008; Lee et al., 2009) have been reported that utilize diffusion-based mixing in
microchannels to generate samples with different concentrations. In such devices, sample
and dilution buffer are mixed using a T/Y-junction and the resultant dilution ratios depend
on hydraulic channel resistances and flow rate parameters. Ismagilov et al.(Song and
Ismagilov, 2003) first used this continuous-flow approach as the input to a droplet
generation channel. The flow rate ratio of sample to diluent was varied to obtain a different
concentration in resulting droplets. Similar techniques with a split-and-combine approach
were used with more complex networks that emulsified droplets(Bui et al., 2011; Yang et
al., 2013) with wider concentration range. These methods suffer from fixed dilution ratios
which cannot be actively controlled due to predetermined channel geometry.

49
Recently, a direct droplet dilution scheme was developed by Niu et al. 2011 where a
parent droplet having a high concentration was trapped in a microchannel using
hydrodynamic resistance and back pressure due to surface tension. Droplets of dilution
buffer were coalesced into it and split in sequence to achieve a 4-order concentration
gradient over 30 droplets. However, trapping the parent droplet required some optimal flow
rate conditions. Different reagents viscosities, interfacial tensions (and thus hydrodynamic
resistance) lead to different trapping conditions. To address these issues, stagnation regions
were used to firmly trap parent droplets, and the dilution buffer stream was passed through
to induce partial diffusion-based mixing leading to a streamwise gradient(Sun et al., 2011;
Sun and Vanapalli, 2013). The stream was then segmented using an immiscible oil phase
through a traditional T-junction to generate varying concentration droplets. However, the
trapped droplets in the stagnation zones are potentially difficult to remove for successive
runs and require flow rate modulation of higher orders. Moreover, in both the above
methods, external pumping was required to generate droplets which complicates chip-toworld interfacing.
Recently, Cai et al. 2012 used of axial dispersion of solute to create concentration
gradients in droplets to perform biochemical screening of enzyme inhibitors. This method
was then utilized by Miller et al. 2009 to perform large scale screening of drug compound
library. However, both methodologies lacked a programmable control over dilution range,
which is a desired feature for any screening application. Also, use of external pumps
permitted droplets to stay inside chips for <3.5 minutes. This method can be challenging
to adopt for studying slower kinetics especially in cell based screening or crystallization
applications.
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4.3

Microfluidic Droplet Dilution Workflow

In this work, we present a dilution protocol by using a programmable microfluidic
component: a three-valve peristaltic pump, to vary concentration from drop-to-drop.
Briefly, a high concentration sample is injected using these on-chip pumps into a steady
stream of buffer. The buffer with the sample pulse and an immiscible oil phase are coflowed through a T-junction in an alternating manner to produce a series of nanoliter
droplets. As the sample pulse advances, the combined effect of diffusion and convection
produces a concentration gradient in the streamwise direction resulting in a droplet
sequence with varying concentration. Furthermore, we demonstrate that by programming
the number of droplets produced after sample injection step, dilution range of a sequence
can be modulated. For preliminary demonstrations, three droplet sequences were created
with 3 fold, 80 fold and 6000 fold dilution. Drop-on demand enables generation of small
number of droplets which can be docked inside the chips till the completion of assay. Such
programmable control is a highly desired feature for broad range of biological screening
applications.
The microfluidic chip was assembled from three separately made layers, a liquid layer,
a gas control layer and a flexible membrane. The fluid and the control layers were
fabricated using an inverse replica molding of poly-dimethylsiloxane (PDMS, 184
Sylguard) with a negative tone SU8-3050 (MicroChem) photoresist. The PDMS polymer
and curing agent were mixed in a 10:1 ratio by weight, poured over the SU8 masters and
baked at 750C for 5 hrs. The channel depths were 40µm for both layers. Part of the PDMS
mixture was spin coated on a glass slide at 1300 rpm for 1300 sec to obtain a thin flexible
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PDMS membrane. The membrane was plasma bonded to the control layer and aligned with
the liquid layer to obtain a three layer assembly. The CAD design of the device is shown
in Figure 27. Three inlet reservoirs were designed for pipetting the dilution buffer (DI
water), a high concentration sample (food colour dyes /Fluorescein) and an immiscible oil
phase (fluorocarbon oil FC3283, 3M Corp.) respectively. On-chip peristaltic pumps were
used to drive all fluids as opposed to external syringe pumps, which are typically used in
droplet microfluidics. The pumps consisted of three normally closed valves(Grover et al.
2006) placed in series, each of which was forced open/close by applying vacuum/pressure
over the flexible membrane layer through control channel lines. Peristaltic flow was
generated by actuating the valves in a 5-phase sequence. The rate of valve actuation was
controlled using a software-programmable microvalve controller unit(Amin et al. 2013)
(Microfluidic Innovations, Indiana). For the current study, the pump period was kept
constant at 2 sec.
Figure 28 shows three principle steps of the microfluidic droplet dilution workflow, 1)
sample injection, 2) axial dispersion and 3) programmable droplet generation. Initially,
dilution buffer is used to prime the microchannels until the end of the injection zone. The
droplet generation channel is primed with a fluorocarbon oil (FC3283). A program is
written that encodes the pump states for each of the three pumps for the entire droplet
dilution workflow. An example of a high level pseudo code is provided in Figure 30.
During the first step, a finite sample volume was injected into the injection zone by
controlling the number of pump cycles. For the purposes of Figure 29, 4 pump cycles were
used to inject a highly concentrated CF488 fluorescent dye into the static buffer. The
sample pulse maintains a sharp profile, since it is primarily subjected to dispersion due to
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molecular diffusion in the static buffer. In the second step, the peristaltic pump driving the
dilution buffer is used to advance this sample plug towards a T-junction (100µm X 100µm).
An axial concentration gradient is set up in the buffer stream owing to the convectiondiffusion process. As a final step, the concentration gradient plug is converted into droplets
of approximately 5.2nL volume with a generation frequency of 0.25Hz. For highly
consistent droplet volumes, the buffer pump and the oil pump pulsed fluids in an alternate
manner into the T-junction. The droplet dilution can be clearly seen in Figure 29 where the
grayscale intensity varies as a function of droplet number.

4.4
4.4.1

Results
Calibration Curve

The dilution protocol resulted in producing train of droplets with varying concentration
owing to axial dispersion. It is imperative to know or to measure the concentration of
sample that each droplet has in order for method to be useful. For evaluating the dispersion
profiles and subsequent concentration gradient in droplets, we used a calibration procedure
using fluorescein and CF488 aqueous dye solution. For calibration, droplets of DI water
and parent fluorescein were generated and imaged using a 14 bit CCD camera (PCO 1600).
First, a train of multiple droplets of known concentration of CF488 dye was created for
each of 0.03µL, 0.06 µL and 0.1 µL dye concentrations. These droplet were imaged using
a CCD sensor and the recorded intensity is as shown in Figure 31. Next, a train of DI water
droplets is generated and its greyscale intensity levels are captured as shown in Figure 32.
Figure 43 shows linear relationship between measured greyscale intensity levels within
droplets having known concentrations of CF488 dye. These intensity levels are used for
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background subtraction and subsequently for estimating dilution factor of a droplet
sequence. For the purpose of this study, the spatial variations in the intensity resulting from
the non-uniformity in the illuminations source have been ignored. The droplet boundaries
were determined using ImageJ software through the use of intensity threshold method. The
dilution factor was then computed by averaging the greyscale intensity level over the pixels
occupied within individual droplets. The measurements were made sufficiently
downstream the T junction using a 20X objective lens to ensure homogeneous
concentration in every droplet. The greyscale fluorescent intensities were recorded as a
function of droplet number. The intensity pulses represent droplets, while oil phases also
contributes to background noise. A calibration curve is formed by subtracting background
intensities from both DI water droplets and fluorescein droplets. Linear relationship exists
where DI water intensity corresponds to zero fluorescein concentration, whereas, recorded
intensity of CF488 corresponds to 0.1mM concentration. This linear curve was used to
estimate the concentration in every droplet upon the dilution protocol. The illumination
intensity and the initial dye concentration were chosen such that it nearly saturated CCD
camera. This allowed maximum utilization of the dynamic range of CCD, thus enabling
measurements of dilution range up to 100 fold. Next, a dilution program was run to obtain
droplet train with varying concentrations. Next, a dilution program was run to obtain
droplet train with varying concentrations. The background greyscale intensity level was
subtracted from the obtained signal, and the outcomes were normalized against the known
sample intensities to obtain a dilution factor. The dilution process was quantified using
CF488 dye (0.1mM) and fluorescein 1mM to estimate the concentration in each droplet
resulting from the combined effect of convection-diffusion under the pulsed flow
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conditions. Figure 34 and Figure 35 shows the variation of dilution factor as a function of
droplet number for fluorescein and CF488 dye respectively. Comparing the two curves, we
found that the bleaching of fluorescein was a significant source of error, lowering the
dilution ratio results. Hence, the fluorescein calibration curve were discarded for later
quantifications. In order to decouple the photobleaching effect from froplet dilution
workflow, we used a more photostable dye, CF488 dye for further quantification of
dilution. . In order to measure the dilution factor over a large range, we used an enhanced
fluorescent dye CF488 at a high concentration (0.1mM) and a high intensity illumination
source. The concentration of CF488 and illumination intensity was adjusted such that it
nearly saturated the CCC sensor array. This enabled measurement of dilution factors as
large as 80 spread across 18 droplets as shown in main text Figure 35. As the droplet
number was increased, concentration measurement for droplets beyond droplet#18 was
obscured with noise levels of the CCD camera. Thus, in this setting, measurements were
limited by dynamic range of CCD. In order to boost the dynamic range of CCD, we used
a neutral density filter with 1% transmittance. First, a sequence of 90 droplets was
programmed with initial sample volume equivalent of 6 pump units. The resultant droplet
array was imaged with and without the neutral density filter. For this measurement protocol,
it is imperative to have high concentration of CF488 and sufficient illumination intensity
that the CCD is nearly saturated even with 1% N.D. filter. We measured a dilution factor
of ~6000 spread across 90 droplets.
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4.4.2

Programmable Control over Degree of Dilution

To further quantify this dilution strategy, we characterized the effect of initial sample
volume and number of droplets generated on the resulting concentration gradient profile.
The droplet sizes were kept constant around 5.2nL using single alternating pump strokes
as previous experiment. During the first step of sample injection, the concentration profile
is nearly rectangular in shape. As this rectangular pulse of sample traverses downstream
under the influence of peristaltic pumps, the peak height of the concentration profile
attenuates; while the pulse width undergoes broadening effect due to combined effect of
advection-diffusion. Hence, the location of T junction for droplet generation and initial
sample volume plays a crucial role in determining the peak height of dilution factor profile.
It is imperative to have at least one droplet in the dilution sequence with concentration
identical to the initial sample concentration from inlet reservoir. The location of T junction
from the point of injection is dictated by geometrical design and cannot be changed
dynamically. Thus, we investigated the effect of sample volume on the peak height of the
dilution factor curve, for the same T junction downstream location. We created droplet
sequences with different initial sample volumes by changing the number of pump strokes
during sample injection step. A program was written (refer Figure 42 for pseudo code) to
execute four replicate droplet sequences for each sample volume. The resulting droplet
dilution factors of the sequence can be seen in Figure 41. Each pulse in the plot represents
a droplet from the dilution sequence. In accordance with the advection-diffusion theory, a
general characteristic trend was observed with peak height of the dilution curve decreasing
with decreasing sample volume. A sample volume equivalent to 4 pump strokes resulted
in a droplet array with peak height of 0.95, while a sample volume equivalent to 1 pump
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strokes resulted in the peak height of 0.2. Based on these experimental observations, we
conclude that minimal of 4 pump stroke equivalent sample volume is needed to obtain the
peak height of dilution curve close to unity. The loss of 5% in the concentration is attributed
to initial mixing of the sample with the residual diluent buffer.
The dilution factor range can be further modified effectively by controlling the
number of droplets produced at T junction after the sample injection step. Figure 38 shows
two droplet sequences, each having same initial sample volume (4 pump strokes), while
the number of droplets produced between successive sample injections are 10 and 18
respectively. The corresponding pseudo code can be found in Figure 40. It can be clearly
seen that the dilution range is different for these sequences. The sequence of 10 droplets
after sample injection produced droplet dilution sequence up to ~3 fold, while sequence of
18 droplets resulted in dilution by ~80 fold. Our programmable microvalve controller unit
allows users to set arbitrary values for number of pump strokes for sample injection,
number of droplets generated per injection and replicates of each sample before the start of
each experiment. Thus, there is no restriction to the number of droplets generated in a
particular sequence per sample injection. To validate this hypothesis, we have measured a
dilution of ~6000 fold by increasing the number of droplets to 90 as depicted in Figure 37
and Figure 39.

4.4.3

Theoretical Framework for Axial Dispersion.

After the injection of a sample pulse, a concentration gradient is set up due to the combined
effect of advection and diffusion. This phenomenon is known as Taylor-Aris dispersion
and has been studies predominantly in channels with circular cross section. The
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concentration at a point sufficiently away from the injection is described by following
convective-diffusion process as shown in Equation (1).

C
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(1)

For the above equation it can be concluded that, it is mandatory that the diffusion
time scales in the transverse direction (normal to the flow direction) are small compared to
advection time scales as depicted by Equation (2) and Equation (3). The T junction should
be placed sufficiently downstream such that transverse diffusion has sufficient time to
smear out the concentration profile (Equation 4).
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The above criterions give the design considerations for geometrical design and pump
operating frequency (high Peclet number) to have droplet dilution workflow in a
convection dominated regime. We found that Peclet number in our design is approximately
of the order 40 which is large enough to ignore diffusion effects in the flow direction. A
theoretical estimate for such convection dominated solute transport can be found in
Equation (5) and Equation (6). Even though a close form expression was obtained for
circular cross sections, however obtaining a close form solution for solute transport for a
pulsatile flow in a rectangular cross section is quite challenging. Nevertheless, all the
concentration profiles at a point sufficiently downstream of injection follow an error
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function form. Thus, to predict the dilution ratio, we formulated a calibration function with
calibration constants, k0, k1, k2, k3 and k4.
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By approximating Deff as 1.5 ×10-8 m^2/s and using curve fitting coefficients: k0= 4.54,
k1=-2.66, k2= 7.78e-5, k3=2.54 and k4= 6.9410-5, a theoretical fit was in Figure 36. Further
experiments are needed to establish a correlation between the calibration constants and
operating conditions such as sample volume, number of droplets generated and frequency
of droplet generation.

4.5

Conclusion

The dilution scheme presented here has many advantages over existing methods. It
uniquely combines the software programmable, valve-based lab-on-chip technology
with the two phase droplet microfluidics approach to vary concentration from drop-todrop. On-chip peristaltic pumping permits on-demand generation of droplets without
requiring any auxiliary external fluid pumping components, thereby simplifying
world-to-chip interfacing. Sample/reagents can be pipetted using an HPLC
autosampler directly into the reservoirs without appreciable dead volumes. The
droplets can be stopped on-demand in the channels for detection, allowing both kinetic
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and equilibrium measurements to yield high quality information. From Figure 37, it
can be seen that the concentration is spread across almost 3 orders within 90 droplets.
Each droplet represents a data point with specific conditions, hence multiple droplets
will lead to high density and statistically high confidence data. The inherent
programmability of the peristaltic pumps mean that scripts with arbitrary set of
instructions can be executed to yield highly complicated droplet patterns, which are
otherwise difficult to generate with external pumping mechanisms. We demonstrated
that the dilution range can be modulated in two ways. First, the amount of sample
injected can be controlled by varying the number of pump strokes. Second, the dilution
range can be increased by increasing the number of droplets generated between
successive sample injections. For the current study, the droplet volumes were one
pump stroke equivalent, however larger droplets can be generated on-demand by
controlling the number of pump strokes during droplet formation process. This feature
can enable coarse to fine screening strategy and will be tested in the future work. For
example, a user can select a custom dilution range with a coarse gradient using large
droplet volumes or a high definition gradient with least droplet volumes. Moreover,
axial dispersion in low Reynolds number flows is a well-studied phenomenon. For a
flow in a convection dominated regime, the concentration gradient becomes
independent of molecular diffusion constant of input sample. Thus, we can built
calibration curves to predetermine the concentration in each droplet, and how it varies
as a function of sample volume, number of droplets and droplet size. An example of
such theoretical calibration function can be found in section 4.4.3.
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All biochemical samples such as proteins/DNAs/small molecules etc. are precious,
as they are extracted with extensive time and cost consuming processes. A microfluidic
platform that can obtain high definition and large amount of information from smallest
sample volumes will be of immense use. As a next step towards building a complete
screening platform, we will develop and integrate droplet merging and mixing module
into the current device. The platform will be used for studying model systems such as
enzyme-inhibition assays for building high quality dose-response data and proteinprotein interactions.
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Figure 27. (a) Microfluidic chip layout showing liquid (blue) and control layer (red)
channels. I/O ports for pipetting fluids and pneumatic signals as well as droplet
storage area are shown. (b) Close-up view showing 3-valve peristaltic pumps for the
dilution buffer, sample to be diluted and the carrier oil phase.

Step 1: Dye ready for injection

Step 2: Sample Injection

Initial high concentration dye sample.

On-chip peristaltic pump for
sample injections

Step 3: Axial Dispersion

Step 4: Droplet break-up

Concentration gradient due to
convection-diffusion process

T junction resulting in droplets with
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Figure 28. Droplet dilution workflow. Samples are injected into a static buffer
stream. In the second step, they are pumped towards a T junction where droplets are
generated. Axial dispersion of samples results ion droplets of varying concentration.
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Figure 29. Concentration gradient in successive droplets. 6 pump cycles equivalent
food color dye was used during injection stage. Dilution can be clearly identified with
decreasing greyscale intensity levels.

General Pseudo Code
Initialize:
Pump 1 for sample; Pump 2 for diluent buffer, Pump 3 for FC3283 oil
1) Set the number of Pump 1 units = X
// (Injected sample volume)
2) Set the number of droplets before next injection = Y
// determine the range of dilution
3) Set the number of repetitions= Z
Execute:
Loop Z times
{
Pump Pump 1

//(replicates of a sequence)
X units
// inject sample to be diluted

Loop Y times // No. of droplets before next injection.
{
Pump Pump 2
1 unit // Droplet production
Pump Pump 3
1 unit // using alternate pumping
}
}

Figure 30. A pseudo code demonstrating pump actuation sequence workflow in droplet
dilution sequence.
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Figure 31. Recorded intensity as a function of time for parent fluorescein droplet of
known concentration (1mM).
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Figure 32. Recorded fluorescein intensities as a function of time for DI water droplets
containing zero fluorescein concentration.
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Figure 33. Fluorescent intensities recorded for a continuous gradient stream 10 mm
away from injection. Different sample injection results in different intensity profiles.
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Figure 34. Droplet dilution factor as a function of droplet number. The fluorescent
intensity measurement were performed using fluorescein and DI water.
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Figure 35. Concentration gradient in successive droplets. Four pump cycles of CF488
fluorescent dye was used during the injection stage. Concentration gradient can be
clearly seen with variable greyscale intensity levels of the inset droplet images.
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Figure 36. Theoretical fit to the dilution factor in a droplet sequence using a calibration
function.
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Figure 37. A sequence of 90 droplets yields a dilution of ~6000 fold.
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Figure 38. Droplet sequences with tunable dilution range. Two droplet sequences are
generated having 3 fold and 80 fold dilution range. By controlling the number of
droplets generated after sample injection, dilution degree can be modulated.
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Initialize:
Pump 1 for sample; Pump 2 for diluent buffer, Pump 3 for FC3283 oil

1) Set the number of Pump 1 units = 4
// (Injected sample volume)
2) Set the number of droplets before next injection = 20
// determine the range of dilution
3) Set the number of repetitions= 1
Execute:
Loop 1 times
{
Pump Pump 1

Loop 90 times
{
Pump Pump 2
Pump Pump 3
}

//(replicates of a sequence)

4 units
// inject sample to be diluted
// No. of droplets before next injection.

1 unit // Droplet production
1 unit // using alternate pumping

}

Figure 39. Pseudo code for a dilution sequence of 6000 fold.

Pseudo Program for Sequence 1

Pseudo Program for Sequence 2

Initialization:

Initialization:

1) Set the number of Pump 1 units =3 (Injected sample
volume)
2) Set the number of droplets before next injection = 5
3) Set the number of repetitions= 4

1) Set the number of Pump 1 units =3 (Injected sample
volume)
2) Set the number of droplets before next injection = 15
3) Set the number of repetitions= 2

Loop 4 times
{
Pump Pump 1

Loop 2 times
{
Pump Pump 1

3 units // inject sample

Loop 5 times
{
Pump 2
1 unit // Droplet production
Pump 3.
1 unit // using alternate pumping
}

3 units // inject sample

Loop 15 times
{
Pump 2
1 unit // Droplet production
Pump 3.
1 unit // using alternate pumping
}

}

}

OUTPUT: Max dilution ratio ~ 3 fold

OUTPUT: Max. dilution ratio ~80 fold

Figure 40. Pseudo code for 3 fold and 80 fold dilution sequences.
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Figure 41. Effect of sample volume on the dilution factor range. It can be seen that
with decreasing initial sample volumes, the peak of the dilution factor decreases due
to combined effect of convection-diffusion. A minimal of 4 pump stroke equivalent
volume is need during the sample injection step.

1) Set the Initial sample volume = 4 pump
strokes
2) Set the number of droplets before next
injection = 10
3) Set the number of repetitions= 4

1) Set the Initial sample volume = 3 pump
strokes
2) Set the number of droplets before next
injection = 10
3) Set the number of repetitions= 4

Loop 4 times // number of replicates
{
//inject high concentration sample
Pump Pump 1
4 units

Loop 4 times // number of replicates
{
//inject high concentration sample
Pump Pump 1
3 units

// droplet production
Loop 10 times // number of droplets
{
Pump Pump 2
1 unit
Pump Pump 3.
1 unit
}

// droplet production
Loop 10 times // number of droplets
{
Pump Pump 2
1 unit
Pump Pump 3.
1 unit
}

}

}

1) Set the Initial sample volume = 1 pump
stroke
2) Set the number of droplets before next
injection = 10
3) Set the number of repetitions= 4

1) Set the Initial sample volume = 2 pump
strokes
2) Set the number of droplets before next
injection = 10
3) Set the number of repetitions= 4

Loop 4 times // number of replicates
{
//inject high concentration sample
Pump Pump 1
1 units

Loop 4 times // number of replicates
{
//inject high concentration sample
Pump Pump 1
2 units
// droplet production
Loop 10 times // number of droplets
{
Pump Pump 2
1 unit
Pump Pump 3.
1 unit
}

// droplet production
Loop 10 times // number of droplets
{
Pump Pump 2
1 unit
Pump Pump 3.
1 unit
}
}

}

Figure 42. Pseudo code for effect of injected sample volume on droplet dilution.
.
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Figure 43. Calibration curve showing linear relationship between CF488 concentration
and the measured greyscale intensity using a CCD camera. The non-zero y-intercept of
the graph for DI water droplets corresponds to the dark noise in the camera. For
subsequent calculation of dilution factor, this value is first subtracted from measured
greyscale intensity within a droplet.
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CHAPTER 5. MICROFLUIDICS FOR TISSUE DIAGNOSTICS

In this chapter, I explain how to integrate the previously discussed valve-based
microfluidics devices to the tissue diagnostic workflow. The chapter starts with a detailed
introduction of the fields of histology and immunohistochemistry based staining techniques
followed by a description of a microfluidic prototype for staining paraffin embedded tissue
sections.

5.1

A Quick Introduction to Tissue Diagnostics

Tissue diagnostics play a crucial role in today’s global healthcare industry with a market
size of approximately $2.5 billion which constitutes about 8% of the total global in vitro
diagnostic market. Tissue testing was responsible for $28 billion in personalized medicine
drugs in 2013 and will continue to grow in coming years owing to the large number of
cancer patient cases throughout the world. Nearly 60% of healthcare decisions depend on
tissue based diagnostics, thus making it an indispensable tool in medicine and clinical
pathology. Tissue diagnostics is widely used for detecting various kinds of diseases such
as inflammatory and infectious as well as for identifying various cancer malignancies.
The typical tissue diagnostics workflow starts with obtaining samples of tissues such as
skin, kidney, liver, lymph node, breast, liver, cardiac, etc. either from patient biopsy or
surgery (refer Figure 44). Tissue sizes vary but are limited to the size of a microscope glass
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slide (3”×1”). Tissue samples are either frozen or processed using a fixative solution to
preserve tissue morphology and prevent any degradation. A common method of tissue
preservation involves usage of a chemical fixative known as formalin which preserves the
cells, its sub-cellular components as well as extra cellular components within the tissue.
Tissues are then processed further to remove their water content. An embedding media
such as paraffin is used to transform the tissue into a solid matrix. Thin sections (4 to 20
µm thick) of these solid paraffin embedded tissues are cut using a machine called,
microtome and deposited on microscope glass slides. The next step in the tissue diagnostic
workflow involves staining the thin tissue slices using an appropriate staining method. This
particular process of staining the tissue for medical examination of a particular disease or
pathogens is known as histopathology. Staining protocols are chosen which are well suited
for the conditions under investigation. The stained slides are observed under a microscope
using bright-field imaging by a trained pathologists for diagnosis and prognosis of the
disease and for determining the treatment strategies for the patients.
Various staining reagents and application protocols are available which allow
pathologists to visualize the tissue morphology and identify any abnormalities present, if
any. It is worthwhile to note that all the tissue slides, without any exceptions, are stained
with a basic primary stain called hematoxylin and eosin (often referred to as ‘H and E’ or
‘H+E’), as a part of routine practices in anatomic pathology clinics and laboratories. It
provides a clear visualization of otherwise transparent tissue by staining the nuclei in violet
blue/purple and cytoplasm, proteins, connective tissues with a pink shade. This staining
method, even though basic in nature, yields an extraordinary level of details about tissue
morphology and cellular makeup, particularly useful in qualitative assessment of cancers.
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The H and E stained tissue sections are observed microscopically by pathologists and
physicians to make timely and appropriate decisions for accurate medical diagnosis. When
the H and E stain is not adequate in yielding confidence for accurate diagnosis, advance
staining techniques, such immunohistochemistry (IHC) and in situ hybridization (ISH), are
often used in conjunction with H and E. Special staining techniques are often used to
identify a certain class of molecules or cells that signal the presence of pathogenic
microorganisms such as tuberculosis. A few examples of such special stains include
toluidine blue for identifying mast cell tumors in skin tissue, mucicarmine stain for
visualization of neural epithelial mucins in the small intestine, dieterle’s stain for localizing
bacterial microorganisms such as borrelia burgdorferi, legionella pneumophila, and
treponema pallidum.
When histologic slides (H and E or special stains) fail to provide concrete answers for
precise diagnosis, advanced staining techniques such as immunohistochemistry (IHC) are
used which utilize advanced molecular biology techniques for the detection of specific
biomarker proteins. IHC is particularly useful in cancer biology, where over or under
expressions of protein biomarkers are directly correlated to mainstream cellular events,
which allows pathologists to determine the presence of a tumor and its sub-classification.
It uses antigen-antibody interactions to detect the biomarker expression levels to show
exactly protein distribution within the tissue. Some of the examples of IHC biomarkers
which are commonly used in therapeutic decisions are CD10 for renal cell carcinoma and
acute lymphoblastic leukemia, epidermal growth factor receptor (HER-2, ER, PR, Ki-67)
for various breast cancers, prostate specific antigen (PSA) for prostate cancers. It is
important to note that primary antibodies used in IHC for detecting biomarkers or target
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antigens within the tissue must be validated using other molecular biology techniques such
as immunoblotting. IHC is particularly effective in detecting presence of malignant tumors
for surgical pathology. Moreover, it has established its utility in screening and validating
of biomarkers for basic research in drug discovery.

5.2

Potential Role of Microfluidics in Tissue Diagnostics

The immunohistochemistry segment of the tissue diagnostic market is expected to grow
at a tremendous rate in upcoming years. Recent reports have shown that one of the main
contributing factors responsible for this growth is the rising number of cancer cases
throughout the world. In the United States, it is estimated that nearly 1.5 million new cancer
cases will be diagnosed every year from 2014. Nearly 1.7 million breast cancer cases were
diagnosed in 2012 alone. Discovery of new biomarkers and adoption of advanced
molecular diagnostic tools are constantly increasing standardization benchmarks in
hospitals, anatomic/pathology laboratories and clinics. It is not difficult to imagine the
estimates for the total number of tissue slides stained every year are quite staggering. In
addition to the new patient slides, bio-banks have archived billions of cancer patient slides
from all over the world in the last few decades which represent a valuable source of
information in studying and understanding the various mechanisms involved in the onset
and growth of cancers.
The first motivation for the incorporation of microfluidic devices into the tissue
diagnostic workflow emerges from the cost control standpoint. The conventional staining
method, commonly known as dip-and-dunk, where slides are dipped in a bath of reagents
(or antibodies in case of IHC) consume nearly 100µL of reagent per tissue slide. There are
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also several key concerns such as potential cross contamination from between sample
slides, lack of controlled active mixing during the dunk operation, etc. Current state-of-theart automated staining platforms from commercial leaders in tissue diagnostics (Roche
Tissue Diagnostics, Leica Biosystems, Dako Diagnostics) consume up to 10-25µL of
reagents per slide. On the other hand, microfluidic devices have the potential for
performing staining with reagent consumption of approximately 100 nL, substantially
reducing the cost per test. Microchannels can be easily created around thin tissue sections
by integrating the microscopic slides with microfluidic chips. The enclosed environment
can be helpful in eliminating evaporation. Miniature pumps can be used to deliver precise
quantities of fluids over the tissue, to obtain the desired staining characteristics. This costeffective strategy can be tremendously helpful for patients in reducing overall cost for
diagnosis and lower the financial burden for diagnosis and treatment. Low volume
consumption is also desired in saving precious antibodies which are not only expensive but
are produced from time consuming and labor intensive processes. Furthermore,
microenvironments around tissue reduce the diffusion times, thus potentially decreasing
the reaction time scales for antibody-antigen binding. The current time scales in IHC for
primary antibodies are on the order of few hours. A microfluidic approach with precise
flow control and an active mixing strategy can minimize these time scales to few minutes.
Furthermore, with reduced assay time scales, microenvironments may result in decreased
adsorption and non-specific binding of antibodies, thus improving overall signal quality.
The second motivation for microfluidics comes from the various enabling features of the
technology such as high processing speeds and an active fluid control. For example, more
information can be extracted from the same tissue sample by locally staining different parts
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of the tissue with different staining reagents. It can allow multiplexed testing of several
biomarkers on a single slide. This feature could be particularly useful in tissue microarrays
(TMA) where several core biopsies are mounted on a single glass slide in a matrix form.
There is no method currently available that can deliver reagents to individual biopsy for
unique biomarkers in IHC protocols. The ability to confine antibodies, reagents and
staining dyes to individual core tissue samples within a TMA is highly desired.
Microfluidic devices with precise fluid manipulation capacity can selectively stain each
tissue spot either with IHC or special stains or simply H and E protocol in a software
controlled environment. Additionally, further microfluidic devices can be added to the
upstream of the staining process, for premixing and diluting staining reagents. This feature
could be particularly useful in optimizing a particular staining protocol for biomarker
validation. In the following sections, a microfluidic prototype, plug and stain platform
(refer Figure 45), is presented for staining paraffin embedded thin tissue sections. The
device is validated by comparing staining results of several tissue sections with three
standard stains , namely hematoxylin, eosin and toluidine blue with reference slides
produced by manual dip-and-dunk staining.

5.3

Manual Staining Protocols

This section describes all the tissue processing steps that were used for staining paraffin
embedded formalin fixed tissue slides. Manual staining was performed to produce control
or reference slides for both qualitative and quantitative comparison of the newly proposed
microfluidic staining method.
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Three separate tissue blocks, for skin with mast cell tumor, kidney and lymph node were
purchased from the Animal Disease and Diagnostic Laboratory at Purdue University. The
tissues were already dehydrated, fixed using formalin and embedded into a non-aqueous
paraffin medium. Thin sections (approximately 5µm thick) were sliced using a sectioning
machine called a microtome and placed over microscope glass slides (3” x 1” Fisher
Scientific). The glass slides were positively charged for enhanced adhesion of the tissue
sections to avoid tissue slippage during the several stages of staining process. There are
five major steps in tissue staining of paraffin embedded tissue sections, deparaffinization,
rehydration, reagent staining, dehydration and cover-slipping. These tissue processing
steps were carried out in 50 mL Eppendorf falcon tubes bought from a commercial vendor
(Fisher Scientific). Deparaffinization is the first step in tissue processing, common to both
histology and immunohistochemistry, where paraffin is removed from the thin tissue
sections on microscopic glass slides. Xylene (certified ACS, Fisher Scientific), a
hydrophobic clearing agent, was used for the complete removal of the embedded paraffin
within tissues slides. The FFPE tissue slides were incubated in two separate xylene
solutions each for 5 min to ensure complete removal of paraffin. Next, the slides were
dipped in a 100% solution of ethyl alcohol (ACS quality, Sigma Aldrich) for dehydration
and complete removal of xylene. The slides were incubated with agitation in two changes
of absolute alcohol, first for 1 min duration and the second for 2 minutes duration. The
slides were dipped in 95% ethanol for another minute before rinsing in tap water to
complete the rehydration process.
The above mentioned steps ensure efficient infiltration of water throughout the thin
tissue sections and restores the aqueous environment within the tissue, making it suitable
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for staining with dyes or antibodies. For this proof-of-concept work, we stained the tissue
sections with three well known histology dyes: hematoxylin, eosin and toluidine blue.
Hematoxylin and eosin together serves as the gold standard and ubiquitously used by
pathologists in the field of clinical pathology. Hematoxylin has a strong affinity towards
basophilic molecules such as DNA/RNA, thus it stains the nuclei with a blue or violet color.
On the other hand, eosin is a pink counterstain and has a strong affinity towards acidophilic
substances such as proteins, cytoplasm, collagen, etc. Toluidine blue is particularly
effective for staining chromosomes and thus widely used in staining and identification of
mast cell tumors. For staining the nuclei with hematoxylin, the deparaffinized slides were
placed in Gill’s III hematoxylin (Sigma Aldrich) solution for incubation times ranging from
a 3 seconds to 15 minutes depending on the type of study. Next, the slides were rinsed off
using tap water to remove excess unbounded hematoxylin. The step was followed by 3 dips
in a differentiation solution (American MasterTech, H & E kit) for removing the
background hematoxylin and controlling the overall stain intensity. This type of staining
approach is known as regressive staining. As a last step in reagent staining for nuclear stain,
slides were dipped into a Bluing reagent (American MasterTech, H & E kit) for 40 sec
which is used to change the solution pH for producing crisp purple stain. The specimen
slides were again rinsed in a running tap water for 3 min to bring the solution pH back to
neutral. For hematoxylin (H+E-) only staining (without eosin as counterstain), the slides
were dehydrated through 4 changes of absolute alcohol to remove any residual tap water.
For both hematoxylin and eosin (H+E+) staining, the slides were incubated for 40 sec in
eosin Y solution (American MasterTech, H & E kit) for effective counterstaining before
performing dehydration steps. In case of toluidine blue stain, the deparaffinized aqueous
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tissue sections were incubated in 0.01% aqueous solution of toluidine blue (Sigma Aldrich)
for 10 minutes followed by 10 dips in tap water. The slides were dehydrated using 10 dips
in 95 % ethanol followed by 10 dips in two successive changes of pure ethanol. After the
dehydration steps, slides were placed in two successive baths of xylene for 3 min each to
clear any residual alcohol. To preserve the stained sections for a prolong duration, the glass
slides were covered using thin glass coverslips (Fisherbrand Cover Glasses: Rectangles).
A mounting medium (Fisher Chemical Permount, Fisher Scientific) was used to adhere the
coverslip to the stained slide. In order to avoid trapping of any air bubbles, the coverslip
was held at 450 allowing the drop of mounting medium to spread slowly along the edge of
the slip. Figure 46 shows several photographs of manually stained sections of skin, kidney
and lymph node using the abovementioned processes.

5.4

Microfluidic Tissue Staining

As elucidated in the earlier section, microfluidic staining devices can play a crucial role
in lowering assay costs by reducing the consumption of invaluable substances such as
antibodies, proteins, etc. There are three principle design considerations that must be
satisfied in order for effective staining of the tissue. First, .the on-chip microfluidic pumps
should generate sufficient pump head to permit reagent delivery out of the chip over a thin
tissue sample. Secondly, drying of deparaffinized sections should not be allowed at any
point of time, before or after the delivery of staining reagents. Tissue drying is extremely
detrimental to the most cellular nuclear contents and leads to loss of information in an
irreversible manner. Finally, the device should be programmable to carry out several
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staining protocols by delivering several reagents successively over the tissue with different
incubation times.

5.4.1

Chip Design and Assembly

In this section, details about microfluidic chip design, operation and staining protocols
executed for validating microfluidic chips are provided. A plug and stain microfluidic
device was designed for direct integration with microscopic tissue slides (Figure 45). The
chip consisted of several on-chip valves and pumps, making the device suitable for various
staining protocols. The device is comprised of four layers and can be reversibly mounted
on top of regular microscope glass slides for an off chip delivery of several reagents. The
schematic for the chip design and its assembly with a tissue slide is illustrated in Figure 48.
Fabrication protocol for the fluidic, control and membrane layers was identical to the
previously designed prototypes as explained in earlier section 2.2. In addition to these three
layers, a 100 µm layer of PDMS was bonded with the fluid layer which acted as a spacer
creating a microchannel when mounted on the top of a tissue slide. Elliptical or circular
cuts somewhat larger than the size of the tissue to be stained, were precut into this spacer
layer. The spacer layer was irreversibly bonded with fluidic layer using oxygen plasma
generated by a hand held corona discharge machine. The fluidic layer had a through hole
facilitating off-chip delivery of staining reagents into the spacer and over deparaffinized
tissue slides (refer section 5.3). The fluidic layer was fabricated by spin coating PDMS
over the SU8 molds at 200 rpm to get an approximate depth of around 100 µm. The thinner
fluidic layers ensured minimal dead volumes and in turn minimal washing times between
successive reagent deliveries. Figure 49 shows a photograph of a paraffin embedded slide
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mounted on top of a microfluidic device. The lead screws were used for a reversible, leak
proof bonding between the device and the tissue slide.

5.4.2

Microfluidic Staining Workflow

Several tissue sections were stained using the microfluidic chips and compared to
manually stained reference slides for qualitative and quantitative comparison. The details
about the quality of staining and comparison with reference slides can be found in the
following section 5.5. In this part, we describe the microfluidic staining workflow that was
adopted for tissue staining. The tissue slides were plugged into the microfluidic manifold
only at the staining reagent delivery step. First, the slides were first deparaffinized off-chip
using the deparaffinization protocol as stated in 5.3. Once the tissue was transferred into a
completely aqueous environment, the tissue slide was immediately mounted over the
microfluidic chip. The thin layer of PDMS ensured a quick and reversible seal with the
microscope slide around the tissue. Care was taken that no air bubble were trapped during
the mounting process and that the seal, even though reversible, formed a sealed
microchamber around the tissue without any leakage. The lead screws from the manifold
exerted sufficient pressure to keep the slide bonded to the spacer layer throughout staining
operation. Next, the desired staining reagents were pipetted into the inlet reservoirs of the
microfluidic chip. The valves and pumps were controlled using a microfluidic valve
actuator by Microfluidic Innovations. The staining reagents were drawn from the inlet
reservoirs and flowed until they completely filled the microchamber. The number of
peristaltic pump strokes or the total time for filling up the chamber was predetermined by
measuring the pump’s average flow rate. The tissue was incubated with the staining reagent
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for different incubation times depending on the protocol. For example, in case of staining
of mast tumor cell, the skin section was incubated for 10 minutes with toluidine blue stain
before washing the tissue with tap water. The time series photographs of the the reagent
entry, incubation and washing can be seen in Figure 52. In case of hematoxylin, the
incubation time was varied from 2 minutes to 15 minutes in order to study the effect on
stain intensity (Figure 50). A two-step staining procedure using hematoxylin and eosin was
carried out over a skin tissue as shown in Figure 51 to demonstrate that the device is
software reconfigurable with user defined control over delivery of various reagents with
different incubation times. First, the tissue was stained with the nuclear stain with a 5 min
incubation time. The tissue slide was detached from the microfluidic device for removing
background staining using a differentiation solution (refer section 5.3) followed by a bluing
reagent. The slide was again remounted over the microfluidic device for delivering
counterstaining reagent, eosin. After the delivery and incubation of staining reagents, the
slides were dehydrated using a series of alcohols and preserved using a cover-slip and a
mounting medium.

5.4.3

Peristaltic Pump Flow Rate Estimation

In order to characterize the microfluidic staining device, we assessed the pump
performance by measuring the net volumetric flow rate. It is important to note that, the
time to fill up the microchamber around the tissue should be at least an order of magnitude
lower than the incubation time for staining protocol. The incubation times for the
histological stains used in this study (hematoxylin, eosin and toluidine blue) were on the
order of 10 mins. The incubation times for immunohistochemistry are typically 1-4 hours.
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Thus, peristaltic pump design and its actuation parameters should be adjusted that yield the
highest possible flow rate for a given design. The flow rate generated by these peristaltic
pump exhibits an optimum owing to the time required for membrane deflection. The
optimal pump frequency is the lowest frequency for which each valve of the pump has a
fully deflected PDMS membrane. For frequencies higher than optimal, the time between
consecutive valves actuations of the pump is lower than time to fully deflect the PDMS
membrane, resulting in flow rates with lower magnitudes. In order to determine the
maximum flow rate generated by the current 3 valve peristaltic pump, we measured the
resulting flow rates by tracking front and rare meniscus of a slug of fluid with known
volume. A known volume, 2µL, of an aqueous food color solution was pipetted in an inlet
reservoir of the device. The peristaltic pumps were started and time was measured for
transferring the entire known fluid volume from an inlet reservoir to an outlet reservoir,
thereby yielding a good estimation of time averaged flow rate. It was made sure that no air
bubble was trapped during the peristaltic pump operation to avoid possible flow rate errors.
A sufficiently large volume of 2 µL ensured lower relative errors introduced with fluid
trapped in the dead volumes of the microfluidic channels. The process was repeated five
times each for several actuation frequencies to resolve the optimal frequency yielding
maximum flow rate value. Figure 47 shows the variation of time averaged flow rate as a
function of actuation frequency for the 3 valve peristaltic pump. The optimal pump
frequency was found to be around 1.25 Hz. For all the following microfluidic staining
studies, the pumps were operated at this frequency to fill up the microchamber around the
tissue as quickly as possible.
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5.5

Qualitative and Quantitative Analysis of Microfluidic Staining

The quality of the microfluidic staining method proposed in this chapter was assessed in
terms of sensitivity, specificity and repeatability of the stained tissue. The reference
microscope slides were stained manually using the protocols stated in section 5.3. For
microfluidic staining, the microscope slides were integrated with the microfluidic devices
only at the reagent delivery step. All the other process were carried out off-chip manually
as per section 5.4.2. Following section describes key results both in terms of qualitative
and quantitative assessment of the microfluidic device.

5.5.1

Staining Sensitivity

Sensitivity of a stain is one of the most basic criteria for qualitative examination of
stained tissues. Irrespective of the amount of regent used, i.e. 50 µL in case of manual dipand-dunk process or 100 nL in case of the proposed microfluidic device, the sensitivity of
stain should be uninfluenced by the method of reagent delivery. Sensitivity of any dye
depends on the affinity between the dye molecules and their target molecules within the
tissue slice. The three commercial histological dyes used in this study (Gill’s 3 hematoxylin,
American MasterTech eosin and toluidine blue) have the appropriate dye chemistry to be
sensitive towards specific parts of the tissue. We used Gill’s 3 hematoxylin to study the
stain sensitivity on lymph node tissue sections. Hematoxylin has an overall positive charge
whereas chromatic substances in the cellular nuclei in the lymph node carry a strong
negative charge, making the tissue suitable for a sensitivity study. Furthermore, it is well
established that hematoxylin stain intensity depends on the amount of incubation time.
Therefore, we stained the lymph node tissue with different incubation times and measured
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the resultant stain intensities. For validating the results obtained from the microfluidic
staining, we also stained lymph node tissue sections with hematoxylin using manual
staining. Five different incubation times were used: 3 seconds, 30 seconds, 2 minutes, 5
minutes and 15 minutes. For the slides stained using the microfluidic device, all the prestaining and post staining processes were identical with the reference slides and were
carried out off chip. Figure 53 shows micrographs of lymph node tissue sections stained
using the manual method as well as microfluidic method for head-to-head comparison. The
proposed microfluidic method showed a good staining sensitivity when compared to the
reference slides. The stain intensities varied across the tissue sample, owing to spatial
heterogeneity of the tissue. In order to compute a representative mean intensity value,
several regions of the tissue were imaged using a 10X objective under a microscope and
their intensities were averaged. An area of the glass slide without a stained tissue section
was imaged and its mean intensity was used for normalization. With increasing incubation
times with the hematoxylin stain, more dye molecules are bound to the cell nuclei, resulting
in an increased stain intensity. Figure 54 illustrates this increasing trend in the variation of
normalized intensity as a function of incubation time. The microfluidic device results in
good staining characteristics with mean intensities in reasonably good agreement when
compared to the reference values derived from manual staining.

5.6

Staining Specificity

The slides stained using the microfluidic device were examined for specificity of
staining. The specific staining corresponds to having dye molecules attach to the specific
regions within the tissue which exhibit high affinity. Thus specificity with low background
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or non-specific binding is an important criterion for determining staining quality. First, we
stained several sections of skin and kidney tissue with nuclear stain, hematoxylin and
microscopically inspected various know morphological features to verify specificity and
background stain. Figure 55, Figure 56 and Figure 57 show very good staining of cell nuclei
for skin tissue, quite similar to specific staining demonstrated by reference slides. The
features which have very positive charge such as connective tissue, red blood cells, fibers,
adipose and smooth muscles were stained very weakly, showing a high degree of
specificity in microfluidic staining. To confirm specificity of the nuclear stain, we stained
thin sections of kidney using hematoxylin. Figure 58 shows similar specificity
demonstrated by a kidney section stained using the microfluidic device when compared to
its reference slide. In order to show that the same device could be used for running several
different protocols, we performed staining of a skin section using both hematoxylin and
eosin. Micrographs of the stained slides show excellent sensitivity and specificity for
different structures within the tissue as seen from Figure 59 and Figure 60. The images
show a distinct color differentiation pattern with different areas of the tissue acquiring
different stain intensities, thus reflecting specific staining. Next, we stained several skin
tissue sections using a toluidine blue stain. The stain is used for determining the presence
and distribution of mast tumor cells, which are difficult to identify with a hematoxylin and
eosin protocol. Figure 61 and Figure 62 show the staining of skin tissue sections using
toluidine blue. Mast cells attracted the dye molecules most and could be easily identified
using both the staining methods. These results effectively demonstrate that tissue sections
stained using the microfluidic devices exhibited desired stain specificity.
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5.6.1

Cross Contamination

Avoiding cross contamination between successive delivery steps is critical for obtaining
the desired staining characteristics. Any fouling can have undesired impacts on disease
diagnosis, thus directly affecting life of patients. The staining reagents used in this study,
both hematoxylin and toluidine blue are prone to precipitation. Prolonged exposure to
atmospheric air can cause formation of solid aggregates within these solutions, potentially
clogging microfluidic channels. This can be quite detrimental since these aggregates may
potentially stick to tissue and could be falsely identified as foreign pathogens. Examples of
such dye deposits can be seen in Figure 63. In order to wash away the precipitates, acid
alcohol was used for cleaning the microfluidic channels after 20 staining runs. As seen
from the figure, the cleaning solution was found compatible with PDMS and was able to
dissolve and wash away any residual hematoxylin precipitates.
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Figure 44. Tissue diagnostics workflow showing tissue preparation, tissue staining and
diagnosis and treatment.

Figure 45. An overview of plug and stain microfluidic platform for tissue diagnostics.
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Figure 46. (top) A 5µm kidney tissue section embedded in paraffin and mounted on a
microscope glass slide. (bottom) Photographs of stained microscopic slides using
manual dip-and-dunk method. Each tissue was stained with hematoxylin, eosin and
combination of the two.
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Figure 47. Plot showing time averaged flow rate of the 3 valve peristaltic on-chip as a
function of pump actuation frequency. The maximum flow rate of observed at a
frequency of around 1.25 Hz.
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Figure 48. (a) Schematic of a specimen tissue slides. (b) The specimen tissue slide can
be directly integrated with the microfluidic device for reagent delivery over thin tissue.
(c) Three distinct layers of microfluidic device, the control, the flexible membrane and
the fluid layer.
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Figure 49. A photograph of microfluidic plug and stain chip assembly. The image shows
staining of toluidine blue over a 5µm tissue section mounted on a glass microscopic
slide. The slide was mounted reversibly with the microfluidic device.

Figure 50. Time series showing the delivery of nuclear stain, hematoxylin, over thin
section of lymph node tissue. The tissue was incubated for 3 minutes before washing
with tap water.
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Figure 51. Time series showing delivery of eosin over a thin section of lymph node prestained with nuclear stain, hematoxylin.

Figure 52. Time series showing three stages of toluidine blue deliver over a skin section
with mast cell tumor. The dye take about 45 seconds to remove the residual water and
fill up the microchamber. After 10 minutes of incubation, tap water was forced through
to clear out the unbounded dye.
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Figure 53. Micrographs of lymph node tissue stained using hematoxylin for different
incubation times. It can be seen that with increasing incubation time, hematoxylin
intensity increases.
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Figure 54. Plot showing the variation of normalized stain intensity of hematoxylin as a
function of incubation time.
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Figure 55. Micrographs showing sections of skin tissue with a nuclear stain. The
microfluidically stained section exhibited specific staining of epidermal layer,
connective tissue and cell nuclei, similar to the reference slide using manual staining.
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Figure 56. Micrographs showing sections of skin tissue with a nuclear stain. The
microfluidically stained section exhibited specific staining of dermis, basale and
granulosum, similar to the reference slide using manual staining.
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Figure 57. Micrographs showing sections of skin tissue with a nuclear stain. The
microfluidically stained section exhibited specific staining of adipose cells and red
blood cells, similar to the reference slide using manual staining.
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Figure 58. Micrographs showing sections of kidney tissue with a nuclear stain. The
microfluidically stained section exhibited specific staining of glomerulus and
Bowman’s space, similar to the reference slide using manual staining.
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Figure 59. Hematoxylin and eosin staining of skin tissue showing color differentiation
pattern. Red blood cells are stained bright red whereas connective tissue is stained with
lowest intensity, demonstrating specific staining.
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Figure 60. Hematoxylin and eosin staining of skin tissue. Microfluidic based staining
reveals excellent staining characteristics as confirmed by the morphological features
such as red blood cells, melanocytes and adipose in the above microphotograph.
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Figure 61. Staining of skin tissue using a toluidine blue stain. The color differentiation
can be clearly seen in both microfluidic and manually stained slides.

100

Manually stained

Mast cell
tumor

Stained using microfluidic chip

Mast cell
tumor

Figure 62. Micrographs showing intense staining of tumor mast cells of skin tissue.
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Figure 63. Effect of dilute alcohol as a washing buffer for clearing deposits of
hematoxylin from the PDMS microchannels.
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CHAPTER 6. CONCLUSIONS AND FUTURE WORK

In this chapter, current and future work is described. The experimental plan is developed
for small molecule inhibitor screening application.

6.1

IC50 Evaluation of β-Galacticosidase Inhibition Assay

CHAPTER 3 and CHAPTER 4 together lay foundation for building a high definition
screening platform. On-chip pumping mechanism using on-chip peristaltic pump allows
working with small samples. Concentration gradient and subsequent merging and
combinatorial mixing are essential for high quality secondary screens. Here, the next steps
are described for developing a programmable platform for inhibitor library screening. As
a first step towards library screening, we will perform a single enzyme-inhibitor
concentration screen for building high definition dose-response curve along with high
quality temporal binding kinetics data. Many droplet microfluidic systems have
demonstrated this application but only with end-point measurements. Conversely, we will
capture the temporal binding-data for different inhibitor concentrations to map out entire
range of enzyme activity. To validate our approach, we will measure inhibition of the βgalactosidase caused by diethylenetriaminepentaacetic acid (DTPA) in the presence of a
fluorogenic substrate, fluorescein digalactosidase (FDG). FDG is chosen because of its
fluorometric readout. As a first step of the assay, the inhibitor DTPA will be diluted to
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produce varying concentrations of DPTA using the droplet dilution scheme discussed
previously. Next, each droplet of enzyme, substrate and varying concentrations of DPTA
will be mixed and the droplets will be monitored for time-resolved measurements. The
fluorescent signal will be recorded by a high frequency camera to track the kinetics of the
reaction. After the completion of reaction, the droplet will then be carried to downstream
waste outlet. As a validation step, we will evaluate IC50 value from our experiments and
compare it with IC50 value of the same system reported in literature. Deliverables: 1) A
multi-point dose-response curve for inhibition of β-galactosidase enzyme by a single
compound diethylenetriaminepentaacetic acid (DTPA) for precise measurement of the
IC50 value, and 2) Time resolved measurements for rate of reaction at each DTPA
concentration to yield a high definition binding dynamics data.

Figure 64. Microfluidic chip schematic for dose response curve for an enzyme inhibition
assay.
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6.2

Moving Towards Multiplexing/Parallelization

In order to screen large number of compounds, multiplexing is essential for high
throughput processing. Ability to screen multiple inhibitors simultaneously can be of
tremendous importance, generating potency data at rapid rates. Parallelization can be
achieved in two ways:
1) Use a single control line to operate large number of valves.
2) Increase the microfluidic controller valve capacity maintaining its individual valve
control.
In the first case, same control infrastructure can be utilized by operating multiple valves
using a same control line. However, it presents optimization problem as vacuum per valve
is reduced. There is also a possibility that the valves away from the main output line lag
the movement considerable. Hence, number of valves in this case need to be determined.

Figure 65. Parallelization by serially connecting control lines.
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